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This study evaluated the effect of a six-week deep slow breathing (DSB) program on 
pain, physical function, and heart rate variability (HRV) in subjects with lower extremity joint 
pain. Twenty subjects were assigned into training (n=10) and control (n=10) groups. The training 
group participated in a six-week DSB program consisting of weekly training sessions and at-
home breathing exercises. DSB exercises focused on prolonging the exhalation and the pause 
following exhalation. The Western Ontario and McMaster Osteoarthritis Index (WOMAC) was 
used to assess pain and physical function and HRV data were obtained pre- and post-
intervention. Results revealed no significant interactions between group and time for any of the 
variables. There was no significant main effect for group, but there was a significant main effect 
(p < 0.025) and a large effect size for time on both pain (training pre 148 ± 94, post 84 ± 89; 
control pre 123 ± 87, post 92 ± 73; group ηp
2 = 0.003, time ηp
2 = 0.454) and physical function 
(training pre 434 ± 268, post 276 ± 287; control pre 482 ± 346, post 338 ± 274; group ηp
2 = 
0.010, time ηp
2 = 0.506). There were no significant main effects (p > 0.017) for group and time 
on LF power (training pre 179.30 ± 562.1 ms2, post 9.82 ± 28.84 ms2; control pre 32.08 ± 66.55 
ms2, post 0.74 ± 0.73 ms2; group ηp
2 = 0.039, time ηp
2 = 0.061), HF power (training pre 14.04 ± 
39.76 ms2, post 7.02 ± 19.24 ms2; control pre 7.43 ± 9.99 ms2, post 1.50 ± 1.87 ms2; group ηp
2 = 
0.039, time ηp
2 = 0.039), and LF/HF ratio (training pre 5.64 ± 10.03, post 2.13 ± 3.72; control pre 
2.38 ± 3.79, post 0.97 ± 0.69; group ηp
2 = 0.036, time ηp
2 = 0.169). Results indicated that the six-
week DSB program was not sufficient to alleviate pain or improve physical function in subjects 
with lower extremity joint pain. As this is the first study to examine the use of DSB for lower 
extremity joint pain and dysfunction, further research is needed to investigate the efficacy and 
applicability of DSB. 
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The Problem and Its Scope 
 
Introduction 
Arthritis is the leading cause of disability among adults in the United States, affecting an 
estimated 50 percent of people age 65 and older. The disease costs the United States 
approximately 128 billion dollars in medical care and lost wages annually and is associated with 
other health disorders such as diabetes, hypertension, obesity, and cancer. Furthermore, half of 
those with arthritis also suffer from cardiovascular disease (Centers for Disease Control and 
Prevention (CDC), 2013), the leading cause of death among both men and women in the United 
States (Centers for Disease Control and Prevention, 2011). 
Osteoarthritis (OA) is the most common form of arthritis, mainly affecting the hands, 
hips, and knees. Those suffering from OA experience a great deal of pain, limiting physical 
activity and decreasing quality of life. Fear of pain or worsening symptoms may discourage 
those with OA from beneficial exercise, leading to other health problems associated with OA 
such as weight gain and heart disease (CDC, 2013). Intervention goals for OA include reducing 
pain, improving quality of life, losing excess weight, and making lifestyle changes that improve 
health such as diet and physical activity. Because pain is the major limiting factor for those with 
OA, most interventions are aimed at reducing pain. However, surgical interventions are 
expensive and non-surgical interventions, such as analgesics, physical therapy, and braces, have 
low efficacy (Losina et al., 2014). Some interventions, such as pain relievers, may produce other 
health complications, including damage to the liver, kidneys, and gastrointestinal (GI) tract (Max 
& Stewart, 2008; Michael, Schlüter-Brust, & Eysel, 2010). 
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Clearly, there is a need for effective non-surgical interventions. Exercise has been 
proposed as an effective and beneficial intervention for those with OA. Exercise reduces pain 
and improves function, quality of life, mood, and confidence to manage health (CDC, 2013). 
Despite the benefits of exercise, 60 percent of people suffering with the disease do not adhere to 
physical activity guidelines and 23 percent are categorized as physically inactive (Austin, Qu, & 
Shewchuk, 2012). This decrease in physical activity (hypokinesis) in those with OA may be a 
result of pain or fear of worsening symptoms with exercise (Austin et al., 2012). Hypokinesis 
progresses OA by increasing stiffness and weakness in the joints and causing metabolic acidosis 
and chronic inflammation making exercise even more challenging (Michael et al., 2010). 
Since aerobic and resistance training are effective non-surgical interventions but many 
with OA will not participate, alternative exercises must be evaluated. Breathing exercises have 
been used for years in a clinical setting to reduce pain and improve health, especially in labor and 
delivery (Lothian, 2011). However, they have not been studied as an intervention for OA. 
Respiration plays an important role in pain signaling and autonomic system activation, emotion 
regulation, acid/base balance, and anti-inflammatory processes (Busch et al., 2012; Chalaye, 
Goffaux, Lafrenaye, & Marchand, 2009; Jerath, Edry, Barnes, & Jerath, 2006; Nepal et al., 
2013). Recent studies suggest that deep slow breathing (DSB) relieves pain (Chalaye et al., 
2009) and improves mood (Busch et al., 2012). Studies in healthy subjects reveal that DSB 
reduces pain by increasing pain threshold, increasing parasympathetic activity (Chalaye et al., 
2009), decreasing sympathetic activity (Busch et al., 2012), and altering pCO2 and pH (Chaitow, 
Bradley, & Gilbert, 2014). Breathing also improves mood, which would largely impact those 
with OA since many suffer from depression as well (Busch et al., 2012). 
3 
 
Deep slow breathing has not been studied as an intervention for OA, but may be an 
effective method for improving pain, function, and mood. This exercise model may be appealing 
to patients with OA because the time commitment and cost are less than traditional therapeutic 
measures. In addition, DSB puts no mechanical stress on the joints and may be relaxing for those 
with OA. As symptoms improve with the use of DSB, those with OA may be more likely to 
participate in other physical activities, resulting in further health benefits. 
 
Purpose of the Study 
The purpose of this study was to determine if a significant difference existed in joint pain 
perception and heart rate variability (HRV) following a six week breathing exercise program. 
The Western Ontario and McMaster Osteoarthritis Index (WOMAC) Visual Analog Scale (VAS) 
is a valid measurement of pain, stiffness, and physical function for those with lower extremity 
joint pain (Averbuch & Katzper, 2004; Ebrahimzadeh et al., 2014). Heart rate variability is 
recognized as an indicator of autonomic nervous system (ANS) activity and assesses the balance 
between parasympathetic (P-ANS) activity and sympathetic (S-ANS) activity (Malik et al., 
1996).  
The goal of the breathing exercise program was to slow the breathing rate and increase 
the pause following exhalation. These exercises may improve pain perception by increasing P-
ANS activity and decreasing S-ANS activity (Chalaye et al., 2009). The breathing exercises may 
also temporarily increase pCO2, resulting in enhanced buffering capacity and altered metabolic 
acid/base homeokinesis. Respiratory and metabolic acid/base homeokinesis affect most 




There will be no significant differences in WOMAC VAS pain and physical function 
scores, heart rate variability (LF, HF, and sympathetic/vagal ratio), and expiratory pause at pre- 
and post-intervention between the training and control groups. 
 
Significance 
As the prevalence of OA rises, cost-effective interventions that target pain are highly 
valuable in a clinical setting. The role of deep slow breathing (DSB) in improving chronic pain is 
not well researched. Specifically, the effect of DSB has not been studied in patients with joint 
pain. Results from this study will provide information about the role of DSB as an intervention 
for joint pain. A better understanding of the effects and mechanisms of DSB may provide novel 
and practical approaches to treating joint pain. 
 
Limitations of the Study 
1. Subjects with hip and/or knee joint pain were selected for this study. The results may not 
be generalizable to those with pain in other joints. 
2. All subjects kept a journal of breathing exercises at home, diet, daily physical activity, 
and medications. Directly measuring these variables was not plausible for this study. 





4. The breathing rate was not specified. The goal of the breathing exercises was to decrease 
frequency and increase depth of breathing by increasing the expiratory pause from pre to 
post intervention. 
5. The trainer and subjects were not blinded in this study. 
6. Control subjects did not attend weekly meetings. Training subjects may have benefited 
from checking in with the researcher as well as group support. 
 
Definition of Terms 
Afferent fibers: A sensory fiber that carries impulses toward the central nervous system (Woolf 
& Ma, 2007). 
Arthritis: Painful inflammation and stiffness of the joints (Michael et al., 2010). 
Central sensitization: Augmentation of responsiveness of central pain-signaling neurons to input 
from low-threshold mechanoreceptors (Woolf & Ma, 2007). 
Chronic pain: Pain that lasts longer than 12 weeks (Schaible, 2012). 
Deep slow breathing (DSB): 6-7 breaths per minute (Busch et al., 2012; Chalaye et al., 2009). 
End tidal carbon dioxide (ETCO2): The level of carbon dioxide in the air exhaled from the body. 
Normal values are 4-6% or 35-45 mm Hg (Jonas, 2005). ETCO2 may be used as a 
predictor of arterial partial pressure of carbon dioxide (PCO2) (Yosefy, Hay, Nasri, 
Magen, & Reisin, 2004). 
Expiratory pause: Holding the breath until the first urge to breathe following expiration (Chaitow 
et al., 2014). 
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Forced expiratory volume (FEV1.0): The volume of air that can be forced out in one second, an 
important measure of pulmonary function (Menezes et al., 2014). 
Heart rate variability: The physiological phenomenon of variation in the time interval between 
heartbeats. It is measured by the variation in the beat-to-beat interval (Malik et al., 1996). 
High frequency (HF) power: power in the high frequency range of 0.15-0.4 Hz (Malik et al., 
1996). HF power is used as an indicator of parasympathetic activity (Chalaye et al., 
2009). 
Hyperalgesia: Increased sensitivity to pain which may be caused by damage to nociceptors or 
peripheral nerves (Woolf & Ma, 2007). 
Hypothalamus: A region of the forebrain below the thalamus that coordinates both the autonomic 
nervous system and the activity of the pituitary, controlling body temperature, thirst, 
hunger, and other homeostatic systems, and involved in sleep and emotional activity 
(Eckberg, Nerhed, & Wallin, 1985). 
Inflammation: A protective tissue response to injury or destruction of tissues, which serves to 
destroy, dilute, or wall off both the injurious agents and the injured tissue. The classical 
signs of inflammation are pain, heat, redness, swelling, and loss of function (Li et al., 
2006). 
Low frequency (LF) power: power in the low frequency range of 0.04-0.15 Hz (Malik et al., 
1996). LF power is used to indicate sympathetic activity (Chalaye et al., 2009). 
Low to high frequency (LF/HF) ratio: The ratio between low and high frequency components of 
heart rate variability represents sympatho-vagal balance (Malik et al., 1996). 
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Metabolic acidosis: A pH imbalance in which the body has accumulated too much acid and does 
not have enough bicarbonate to effectively neutralize the effects of the acid (Robergs, 
Ghiasvand, & Parker, 2004). 
Minute ventilation (VE): The volume of gas inhaled or exhaled from a person’s lungs per minute 
(Cooper et al., 2003). 
Neuropathic pain: Pain arising from disease or injury to the thermo-nociceptive component of 
the nervous system at any level (Schaible, 2012). 
Nociceptors: Sensory receptors that are preferentially sensitive to tissue trauma or a stimulus that 
would damage tissue if prolonged (Woolf & Ma, 2007). 
Osteoarthritis: A disease of the entire joint involving the cartilage, joint lining, ligaments, and 
underlying bone (Michael et al., 2010). 
Pain threshold: The point at which a stimulus, usually one associated with pressure or 
temperature, activates pain receptors and produces a sensation of pain  
 (Chalaye et al., 2009). 
Pain tolerance: The greatest level of pain which a patient is able to withstand  
 (Chalaye et al., 2009). 
Parasympathetic autonomic nervous system (P-ANS): A branch of the autonomic nervous 
system that slows heart rate, increases intestinal and glandular activity, and relaxes the 




Peripheral sensitization: A lowering of the stimulus (pain) threshold for nociceptor activation and 
an increase in the frequency of nerve impulse firing (hyperexcitability). Peripheral 
sensitization can contribute to pain hypersensitivity found at the site of tissue 
damage/inflammation (Woolf & Ma, 2007). 
Power spectral density (PSD): provides the basic information of how power distributes as a 
function of frequency (Malik et al., 1996). 
Standard deviation of the NN intervals (SDNN): the square root of variance. SDNN reflects all 
the cyclic components responsible for variability in the period of the heart rate variability 
recording (Malik et al., 1996). 
Sympathetic autonomic nervous system (S-ANS): A branch of the autonomic nervous system 
that accelerates heart rate, constricts blood vessels, and raises blood pressure (Eckberg et 
al., 1985). 
Vagus nerve: The tenth pair of cranial nerves, supplying the heart, lungs, upper digestive tract, 
and other organs of the chest and abdomen (Eckberg et al., 1985; Marek, Muckenhoff, & 
Prabhakar, 2008). 
Western Ontario and McMaster Universities Arthritis Index (WOMAC): The WOMAC is a 
widely used, proprietary set of standardized questionnaires used by health professionals 
to evaluate the condition of patients with osteoarthritis of the knee and hip, including 






Review of Literature 
 
Introduction 
Osteoarthritis (OA) is a form of arthritis in which the proteins that make up the articular 
cartilage begin to degrade. Repetitive stress on the joint leads to degeneration of the cartilage 
causing pain, swelling, and stiffness. As OA progresses, the articular cartilage begins to flake or 
form cracks. In advanced stages, the articular cartilage may be absent causing friction, 
degradation of the bones, and stimulation of bone spurs resulting in more joint pain and swelling 
(Michael et al., 2010). Since current non-surgical pain management approaches have low 
efficacy (Losina et al., 2014), novel approaches are needed. It is difficult to treat OA pain 
because the exact cause of OA pain is unknown. Pain is, however, related to autonomic nervous 
system (ANS) activity and may be mediated by altering ANS activity (Busch et al., 2012; 
Chalaye et al., 2009). Deep slow breathing (DSB) alters ANS activity and has been used for 
years to reduce pain and improve health. DSB has not been studied as a method for relieving OA 
pain, but may be a suitable intervention to improve pain, physical function, and mood (Busch et 
al., 2012; Chalaye et al., 2009; Losina et al., 2014). 
 
Etiology of Osteoarthritis 
The exact cause of OA remains unknown, but it is likely due to an interplay between 
systemic and local factors. The etiology involves both genetic and non-genetic factors (Felson, 
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2004). Risk factors for developing OA include age, female gender, weight, ethnicity, joint injury, 
repetitive overuse of the joint, low physical activity, low bone density, muscle weakness, joint 
laxity, malformation, malposition, metabolic and endocrine disorders, alcohol and tobacco use, 
and nerve injury (Michael et al., 2010). OA is also associated with other chronic diseases, such 
as diabetes and heart disease. The relationship between OA and other diseases remains unclear, 
but obesity and lack of physical activity are the main risk factors for developing these chronic 
diseases (Michael et al., 2010). 
 
Management of Osteoarthritis 
Management of OA is important because pain related to this disease results in limited 
physical function, decreased ability and willingness to exercise, and increased body fat, which 
severely and negatively impact health and life expectancy. Because pain plays such an integral 
role in the etiology of OA, the goal of most interventions is to reduce pain. Even though 
interventions are aimed at decreasing pain, relatively few are successful and few prevent 
progression of the disease. Some interventions, such as analgesics, are even harmful. Despite the 
variety of interventions available to those with OA, Losina et al. (2014) report that over half of 
people with knee OA will require a joint replacement during their lifetime. This demonstrates the 
low efficacy of non-surgical interventions and the need for conservative and effective 
management approaches. 
Physical activity is recommended to reduce pain and improve function, mood, and body 
composition (CDC, 2013). Exercise recommendations for patients with OA consist of 150 
minutes of low impact, moderate intensity aerobic exercise per week combined with two days of 
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resistance training. Even 60 minutes of moderate intensity exercise per week improves pain, 
function, and health in those with OA (Lubar et al., 2010). Despite the benefits of exercise, most 
people with OA do not meet these recommendations and many are physically inactive (Austin et 
al., 2012). Pain and fear of worsening symptoms with exercise are reported as major barriers to 
physical fitness (Lubar et al., 2010). 
As a result of these barriers to exercise, more research is needed to identify novel and 
non-invasive approaches to managing OA. Effective interventions must aim to reduce pain and 
enable those with OA to make healthy lifestyle changes. Breathing techniques have been used 
for years in a clinical setting to reduce pain and improve health, especially in labor and delivery 
(Lothian, 2011). Respiration plays an important role in pain signaling, autonomic nervous system 
activation, emotional regulation, acid/base balance, and anti-inflammatory processes. 
Respiration’s involvement in many physiological processes as well as the brain’s ability to 
consciously control breathing qualify it as a possible intervention for OA. Studies in healthy 
subjects reveal that deep slow breathing (DSB) reduces pain by increasing pain threshold, 
increasing parasympathetic activity (Chalaye et al., 2009), decreasing sympathetic activity 
(Busch et al., 2012), and altering pCO2 and pH (Chaitow et al., 2014). DSB also improves mood, 
which would help with depressive symptoms associated with OA (Busch et al., 2012). 
DSB has not been studied as an intervention for OA, but may be an effective method for 
improving pain, function, and mood. This exercise model may be appealing to patients with OA 
because the time commitment and cost are less than traditional therapeutic measures. In addition, 
DSB puts no mechanical stress on the joints and may be relaxing for those with OA. As 
symptoms improve with the use of DSB, those with OA may be more likely to participate in 
lifestyle changes, such as exercise, that provide further health benefits. 
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Measurement of Osteoarthritic Pain and Functional Limitation 
To evaluate the effect of OA interventions, a valid and reliable measurement must be 
used. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is one of 
the most commonly used self-reported measures of lower extremity symptoms and function. It 
was specifically designed to evaluate pain, function, and stiffness in subjects with OA of the hip 
and knee. The WOMAC has been studied for over 30 years in various contexts and in subjects of 
different ethnic backgrounds. The WOMAC is supported as a valid and reliable measurement of 
pain and function in subjects with hip or knee OA (Bellamy, Buchanan, Goldsmith, Campbell, & 
Stitt, 1988; Dunbar, Robertsson, Ryd, & Lidgren, 2001; McConnell, Kolopack, & Davis, 2001; 
Pua, Cowan, Wrigley, & Bennell, 2009; Wolfe & Kong, 1999). 
The WOMAC is easy to use and minimal training is needed. The test takes about 12 
minutes to administer. A copy of the WOMAC and a ruler for the visual analog scale (VAS) 
version are the only equipment needed. Subjects use the VAS to answer 24 questions about pain, 
function, and stiffness. The VAS is 100 mm long and uses anchors of no pain/stiffness/difficulty 
to extreme pain/stiffness/difficulty. Subjects mark along the 100 mm continuum. A ruler is then 
used to score the items. Items for each subscale are summed. Possible ranges for pain, stiffness, 
and function are 0-500, 0-200, and 0-1700, respectively. Usually, total WOMAC score is 
calculated by summing totals from each subscale. A higher score indicates worse pain, functional 
limits, and stiffness (Bellamy, 2002). 
The validity, reliability, and convenience of the WOMAC make it a good measurement 
tool for studies regarding pain and function in those with hip and knee OA. For examination of 
individual patients, determining the minimal meaningful change in WOMAC scores can be 
challenging. The minimal clinically important improvement (MCII) value, defined as the 
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smallest change in measurement that indicates substantial improvement in symptoms, may be 
used to determine the importance of WOMAC change scores. MCII values for hip and knee OA 
are identified as -15.3 mm and -19.9 mm respectively, for pain, and -7.9 and -9.1 respectively, 
for physical function (Tubach, 2005). This measurement tool may be applied to studies 
examining the efficacy of pain interventions for hip and knee OA. 
 
Neurophysiology of Osteoarthritic Pain 
In order to understand the role of interventions in mitigating pain, it is imperative to 
understand what causes pain and how it is processed. Despite the clinical importance of 
understanding pain, there is surprisingly little research on pain compared with other health 
conditions. This may partly explain the lack of effective interventions for the chronic pain 
associated with OA. 
Function of pain. Pain plays an integral role in protecting the body from damaging or 
potentially damaging stimuli. Potentially damaging stimuli are detected by nociceptors: highly 
specialized sensory receptors of the peripheral somatosensory nervous system. These receptors 
detect noxious stimuli and send electrical signals to the central nervous system. Nociceptors are 
located in the viscera, muscles, joints, meninges, and skin and are stimulated by mechanical, 
chemical, or thermal stimuli. Nociceptors are the free nerve endings of primary afferent Aγ and 
C fibers. Aγ fibers are small in diameter and lightly myelinated. Aγ fibers respond to mechanical 
and thermal stimuli and result in fast, sharp pain. They are responsible for the reflex response to 
acute pain. C fibers are the smallest of primary afferents and are unmyelinated. They have the 
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slowest conduction and respond to chemical, mechanical, and thermal stimuli. Activation of C 
fibers results in chronic, slow, burning pain (Woolf & Ma, 2007). 
Upon activation, primary afferent fibers synapse with secondary afferent neurons in the 
dorsal horn of the spinal cord and information is sent to the higher centers in the brain. There are 
two main pathways by which these signals are sent: the spinothalamic tract and the spinoreticular 
tract. In the spinothalamic tract, secondary afferents ascend in the contralateral spinothalamic 
tract to nuclei within the thalamus. Third order neurons then ascend to the somatosensory cortex 
or the periaqueductal grey matter (PAG). In the spinoreticular tract, fibers ascend the 
contralateral cord to reach the brainstem reticular formation. Then, they are projected to the 
thalamus and hypothalamus. There are many further projections to the cortex. The spinothalamic 
tract transmits signals that are important for pain localization and the spinoreticular tract is 
involved in emotional aspects of pain (Schaible, 2012; Sofat, Ejindu, & Kiely, 2011; Woolf & 
Ma, 2007). 
Once the noxious signal reaches the brain, it is processed by the higher brain centers. 
Pain is highly individualized and subjective, making it difficult to study. It is affected by mood, 
beliefs, genetics, and cognition (Max & Stewart, 2008; Rainville, 2002; Tracey & Mantyh, 2007; 
Wiech, Ploner, & Tracey, 2008; Wiech & Tracey, 2009). Studies using functional magnetic 
resonance imaging (fMRI) show that a large brain network is stimulated when pain is perceived. 
The most commonly activated brain regions include the primary and secondary somatosensory 
(S1 and S2) cortices, insular cortex, anterior midcingulate cortex, posterior cingulate cortex, 
orbitofrontal cortex, prefrontal cortex, and the thalamus. Studies evaluating the validity of pain 
scales suggest that rated pain directly corresponds to brain activity, supporting the argument that 
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pain is highly individualized. Some experience noxious stimuli more intensely than others. These 
brain regions must play an important role in pain processing (Kulkarni et al., 2007). 
It is clear that the pain pathways are activated during OA, but what causes the associated 
pain to begin and why does it persist? Since the exact cause of OA is unknown, it is difficult to 
answer these questions. In many cases, OA is probably due to a combination of mechanical 
stress and humoral factors released by adipose tissues. These factors result in damage to the 
articular cartilage and surrounding joint tissues. The damaged tissues release protons and other 
inflammatory mediators, causing inflammation, lowering local pH, and resulting in sensitization 
of the nociceptor (Sofat et al., 2011). 
Peripheral sensitization. Normally, the pain threshold is high and only stimuli that are 
actually or potentially damaging are detected. In OA, acidosis and inflammation cause 
depolarization and sensitization of the nociceptors. Sensitization decreases the threshold and 
increases responsiveness of the nociceptors to non-noxious stimuli. Some of the sensitizers 
present with OA are kinins, amines, prostanoids, growth factors, chemokines, cytokines, protons, 
and adenosine triphosphate (ATP) (Woolf & Ma, 2007). These sensitizers work by binding to 
their specific receptor on the nociceptor membrane. This binding occurs as a result of activation 
of intracellular signal transduction pathways (Doya et al., 2005; Hucho, 2005; Jin & Gereau, 
2006; Malik-Hall, Dina, & Levine, 2005; Mizushima et al., 2007; Varga et al., 2006). Other 
effectors include phosphorylation of transient receptor potential (TRP) and voltage-gated sodium 
channels which alter thresholds and kinetics (Woolf & Ma, 2007). 
Sensitization results in a heightened state of sensitivity. Stimuli that are normally 
innocuous may be detected as noxious stimuli. Heightened pain sensitivity can be beneficial by 
reducing use of or contact with the injured joint. However, persistent changes in nociceptor 
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function are pathological and contribute to OA pain. Typically, restoration of the nociceptor to 
normal function would suffice. With OA, this does not work because the inflammation will still 
be present and drive the depolarization of these sensory neurons. In advanced stages of OA, 
chronic pain when no stimulus seems to be present may be explained by sensitization. With a 
reduced threshold, normal body temperature or blood vessel pulsation may stimulate low 
threshold nociceptors and result in pain (Woolf & Ma, 2007). 
Central sensitization. In addition to peripheral sensitization by localized noxious 
stimuli, structural and biochemical changes may also occur in the systems that perceive pain 
(Sofat et al., 2011). Pathological input from the joint may cause complex changes in the central 
nervous system, known as central sensitization. With central sensitization, nociceptive neurons 
become hyperexcitable and the processing of noxious stimuli is amplified. Central sensitization 
has both spinal and supraspinal components (Schaible et al., 2009). Central sensitization is seen 
in advanced stages of OA. Methods of this sensitization remain unknown and are difficult to 
study (Schaible, 2012). 
Acid-sensing ion channels. Protons which are involved in sensitization may also be 
detected by acid-sensing ion channels (ASICs). These protons are released by damaged tissue 
and decrease the pH in the joint. This change in pH is detected by ASICs, which may function as 
a specific type of nociceptor. It is unknown whether ASICs transduce or mediate noxious stimuli. 
However, since ASICs are highly sensitive to pH, they are considered to be closely linked with 
pain processing (Voilley, 2004). 
Local pH often drops below 7 with inflammation, infection, ischemia, and exercise 
(Goldie & Nachemson, 1969; Rehncrona, 1985). This dramatic change is detected by ASICs and 
a signal is sent to the brain. ASIC expression and currents are increased with experimentally 
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induced inflammation in the rodent paw (Voilley, de Weille, Mamet, & Lazdunski, 2001) and the 
mouse knee (Masahiko Ikeuchi, Kolker, & Sluka, 2009; M. Ikeuchi, Kolker, Burnes, Walder, & 
Sluka, 2008). This supports the hypothesis that ASICs have a nociceptive function. ASICs may 
be related to neuropathic pain. Compression of the spinal nerve root causes both hyperalgesia 
and increased expression of ASIC3 (Ohtori et al., 2006). This suggests a potential mechanism for 
neuropathic pain. Ivanavicius et al. (2007) suggest that OA pain has a neuropathic component. 
Neuropathic pain. Neuropathic pain is non-nociceptive and initiated by a lesion or 
dysfunction of the nervous system. Pain caused by the nerve injury could be a result of both 
peripheral and central sensitization in combination with local inflammation. Studies using the 
monoiodoacetate (MIA) pain model support the theory that OA pain may be partially due to 
neuropathy (Ivanavicius et al., 2007; Orita et al., 2011). In this model, MIA is injected into the 
joint and arthritis symptoms develop rapidly, unlike actual OA. MIA blocks glycolysis and is 
toxic for chondrocytes. Twenty four hours post-injection, chondrocytes shrink, fragmented 
pyknotic nuclei appear, synovial membrane is expanded by fibrin proteinaceous edema fluid, and 
the joint is invaded by lymphocytes, macrophages, and plasma cells. Days later, the 
inflammatory response in the synovium subsides, necrotic cartilage collapses, and chondrocytes 
are lost. Osteoclastic activity is increased, subchondral bone collapses, and fragmentation of 
bone trabeculae are surrounded by osteoclasts and some replacement by fibrous tissue and newly 
laid trabecular bone appear (Schaible, 2012). With MIA injection, a high number of neurons in 
the dorsal root ganglia (DRG) express ATF-3 immunoreactivity, suggesting neuropathic pain 
(Ivanavicius et al., 2007; Orita et al., 2011). Furthermore, upregulation of galanin and 
neuropeptide Y, downregulation of substance P and CGRP in DRG neurons (Im et al., 2010), 
and activation of spinal microglia (Orita et al., 2011) were found. Similar differences were seen 
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with a surgical model (Orita et al., 2011). In a study by Ivanavicius et al. (2007), rats with OA 
showed increased sensitivity to gabapentin, a molecule used to treat neuropathic pain in humans. 
These studies provide further evidence for a neuropathic component in OA pain. 
Central pain processing. In addition to these mechanisms, neuroimaging studies, 
including functional magnetic resonance imaging (fMRI) and positron emission tomography 
(PET) scans, have revealed that structure and activity of pain processing brain regions are altered 
with OA. Baliki et al. (2008) measured brain activity in response to noxious mechanical knee 
stimulation in subjects with knee OA. Results showed that noxious knee stimulation was 
associated with bilateral activity in the thalamus, secondary somatosensory, insular, and 
cingulate cortices, and unilateral activity in the putamen and amygdala. Local lidocaine treatment 
of the knee reduced brain activity seen on fMRI for these regions. 
Kulkarni et al. (2007) used PET and compared brain activity between patients with 
arthritic knee pain, experimental knee pain, and no pain. With arthritic pain, regional cerebral 
metabolic rate for glucose (rCMRGlu) was bilaterally enhanced in all areas of the brain involved 
in pain processing: posterior cingulate cortex, anterior midcingulate cortex, prefrontal cortex, 
orbitofrontal cortex, and primary somatosensory cortex. Unilateral activations were seen in the 
thalamus, anterior perigenual cingulate cortex, amygdala, and supplementary motor area. The 
most statistically significant activity observed with arthritic pain was in the anterior cingulate 
cortex, although activation spanned from anterior to posterior midcingulate region (Kulkarni et 
al., 2007). The cingulate cortex is a fundamental part of the limbic system and appears to play an 
important role in the emotional processing of pain perception (Price, 2000). 
Interestingly, when arthritic and experimental pain were compared, arthritic pain was the 
only pain associated with increased activation of the limbic system, involved in affect, aversive 
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conditioning, and motivation. This may explain why many people with OA also suffer from 
anxiety, depression, and other psychological disturbances. In addition to over-activation of pain 
processing centers, those with OA exhibit atrophy of the thalamus (Kulkarni et al., 2007) and the 
gray matter of pain-related cortical areas (Hess et al., 2011). These atrophies were reversible 
after arthroplasty suggesting that atrophy is more likely a side effect than a cause (Rodriguez-
Raecke, Niemeier, Ihle, Ruether, & May, 2009). 
Descending pathways. Descending neural pathways may also contribute to OA pain. 
Neural pathways descending from the brainstem play an important role in balancing inhibition 
and facilitation of nociception. The diffuse noxious inhibitory control (DNIC) is a form of 
inhibition that is dysfunctional in those with severe OA. Function is restored following joint 
replacement. Other studies reveal that with OA, serotoninergic descending facilitation (Rahman 
et al., 2009), as well as increased activation of the periaqueductal gray (PAG) in the brain stem 
(Gwilym et al., 2009) play a role in OA pain. These studies suggest that an imbalance between 
inhibitory and excitatory descending systems could play a role in OA pain generation (Schaible, 
2012). 
Autonomic nervous system activity. The ANS plays an important role in homeostasis 
and adaptive responses to stress, including pain (Cortelli, Giannini, Favoni, Cevoli, & Pierangeli, 
2013). The parasympathetic ANS (P-ANS) and the sympathetic ANS (S-ANS) are both involved 
in pain perception and regulation. In chronic pain, the balance between P-ANS and S-ANS 
activity becomes disturbed. Specifically, P-ANS activity decreases and S-ANS activity increases 
(Dowling, 1982, 1983; Tracy et al., 2015). Heart rate variability (HRV) is often used to assess 
ANS activity. High frequency (HF) power is used to denote parasympathetic activity and low 
frequency (LF) power is used to denote sympathetic activity, although LF power may more 
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accurately indicate a combination of parasympathetic and sympathetic activity (Chalaye et al., 
2009).  
In studies of subjects with chronic pain, increased pain was associated with decreases in 
HF power and LF/HF ratio and increases in LF power, confirming a decrease in parasympathetic 
activity and an increase in sympathetic activity with chronic pain (Busch et al., 2012; Chalaye et 
al., 2009; Fischer et al., 2015; Tracy et al., 2015). The relationship between pain and ANS 
activity is also substantiated by the positive correlation between pain and cortisol levels (Fischer 
et al., 2015; Goodin et al., 2012) and the positive correlation between pain and skin conductance 
levels (Busch et al., 2012; Loggia, Juneau, & Bushnell, 2011). Increased cortisol levels and 
increased skin conductance levels are both indicative of greater S-ANS activity (Busch et al., 
2012; Goodin et al., 2012; Loggia et al., 2011). The role of the ANS in responding to and 
mediating pain may be important in understanding and targeting chronic pain. 
Targeting osteoarthritic pain. Treating OA pain is difficult since the origin and cause of 
pain are not yet elucidated. Further research on pain mechanisms and pathways will help provide 
more effective management options for those suffering with OA. Currently, most pain therapies 
aim to block nociception or neutralize cytokines and inflammatory factors involved in 
nociception. This is problematic for a number of reasons. It is important that normal nociception 
is maintained with these interventions to protect the body from undetected tissue damage 
(Schaible, 2012). Additionally, there will always be more inflammatory mediators readily 
available to sensitize the nociceptor, causing pain and further damage in those with OA. To date, 
one medication cannot target all sensitizers (Woolf & Ma, 2007). An intervention that targets the 
source of pain and the pathways involved rather than the signal produced may be more effective 
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for those suffering with OA. Breathing may be a suitable alternative approach that targets local 
and systemic factors involved in pain processing. 
 
Deep Slow Breathing to Improve Osteoarthritic Pain 
Deep slow breathing (DSB) is often used in a clinical setting to relieve pain or improve 
health. Practices that utilize DSB include Lamaze (Lothian, 2011), yoga (Sovik, 2000), qi-gong 
(Li & Yeh, 2005), pranayama (Singh, Malhotra, Singh, Madhu, & Tandon, 2004), tai chi (J. X. 
Li, Hong, & Chan, 2001), relaxation (Chalaye et al., 2009) and Buteyko breathing (Chaitow et 
al., 2014). Despite the widespread use of DSB, there are relatively few studies examining the 
effect of deep breathing as an analgesic (Chalaye et al., 2009). Specifically, there is currently no 
research examining the use of DSB as an analgesic for osteoarthritis. Most research on DSB and 
pain is conducted using healthy subjects or those with cardiovascular disease. This research 
suggests that there is a strong relationship between autonomic activity and pain perception. It is 
proposed that DSB functionally resets the autonomic nervous system and synchronizes neural 
function in the heart, lungs, limbic system, and cortex (Jerath et al., 2006). In a study by 
Chambers, Taddio, Uman, and McMurtry (2009), breathing exercises significantly reduced pain 
reported by children during immunizations and distress observed by parents or nurses. A few 
studies have examined possible mechanisms of DSB in providing pain relief (Busch et al., 2012; 
Chalaye et al., 2009; Jerath et al., 2006). 
Altered pain threshold. DSB may decrease pain by increasing the pain threshold of 
nociceptors. Chalaye et al. (2009) examined the effect of DSB on experimental heat pain and 
autonomic cardiac activity. They compared natural breathing to DSB (six breaths per minute), 
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rapid breathing (16 breaths per minute), breathing with a distraction (playing a video game), and 
a biofeedback control where subjects synchronized their breathing and heart rate. Respiratory 
rate and depth were measured with a piezo-electric respiratory belt transducer. 
Chalaye et al. (2009) hypothesized that DSB and heart rate (HR) biofeedback would 
produce the strongest analgesic effects and greatest cardiac changes. Results revealed significant 
differences between the groups for thermal pain threshold and tolerance. Mean pain threshold 
values significantly increased from baseline following HR biofeedback (+1.6° C, p<0.005), DSB 
(+1.0° C, p<0.05), and breathing with a distraction (+1.1° C, p<0.05). Mean pain tolerance 
values significantly increased following HR biofeedback (+0.7° C, p<0.005) and DSB (+0.5° C, 
p<0.005). Contrariwise, rapid breathing was followed by a decrease in pain threshold (-0.2° C) 
and no change in pain tolerance although these results were not statistically significant. 
DSB and HR biofeedback had the largest impact on pain thresholds and tolerances. DSB 
had an analgesic effect whether it was done before or after rapid breathing. Rapid breathing had 
no analgesic effect regardless of the order in which the subject completed the different breathing 
conditions. In this study, the intensity range from pain threshold to pain tolerance was only 3.3 
degrees Celsius. Average changes in thermal pain thresholds were about 1 degree Celsius higher. 
This may seem unimportant, but when considering the exponential function linking temperature 
and pain, a one degree increase will produce great changes in perceived pain (Chalaye et al., 
2009). 
Similarly, Busch et al. (2012) examined the effects of DSB on pain perception and 
sympathetic arousal in 15 healthy subjects. They specifically examined the difference between 
attentive versus relaxed DSB. The methods of breathing were similar for both groups. The 
attentive DSB (aDSB) subjects breathed according to a respiratory feedback task. They were 
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presented with an ideal breathing curve including frequency and depth. Their own breathing 
curve was simultaneously shown to them on a screen with the ideal curve. They were asked to 
match their breathing with the ideal curve, requiring their attention and concentration.  
The relaxed DSB (rDSB) subjects were told to concentrate on the experience of 
breathing. They received verbal instruction during the experiment in order to keep respiration 
rates similar to the aDSB condition. The rDSB condition was more similar to a meditative state 
and required little cognitive processing. A respiration rate of 7 cycles per minute (cpm) was used 
for both groups. The ratio of expiration/inspiration/pause was 60/30/10 (Busch et al., 2012), as 
suggested by previous literature (Cappo & Holmes, 1984; Strauss-Blasche et al., 2000).  
Busch et al. found a significant increase in pain thresholds of subjects after only three 
microcycles of rDSB. aDSB did not alter pain thresholds suggesting that relaxation is an 
important part of DSB. This is supported by other research that suggests DSB may reduce pain 
intensity rating compared with rapid breathing (Grant & Rainville, 2009). This study was not 
able to demonstrate a difference between relaxation and deep breathing, but they lacked a control 
group. This actually supports the claim that relaxation is an essential component of pain 
perception attenuation. The argument could be made that aDSB is more distracting than rDSB, 
but Busch et al. counter this by arguing that some individuals may be just as distracted by 
concentrating on certain distracting thoughts during rDSB, just as some may be distracted by 
matching their curve to the ideal respiratory curve. 
Sympathetic nervous system activity. DSB may decrease pain by altering autonomic 
nervous system activity. Busch et al. (2012) measured sympathetic activity by measuring skin 
conductance levels (SCLs). Results showed significant decreases in SCL in all cycles during the 
rDSB condition, signifying slowing of sympathetic activity. Pain thresholds and SCLs were 
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inversely correlated for rDSB. The inverse correlation suggests that sympathetic activity plays an 
important role in pain perception. Slowing of the sympathetic system may mediate pain. Other 
studies report that basal electrodermal activity is significantly reduced during meditation (Travis, 
2001), mindfulness-based stress reduction (Lush et al., 2009), or integrative body-mind training 
(Tang et al., 2009).  
Alternatively, aDSB increased sympathetic arousal. Other studies corroborate this 
finding. Cappo & Holmes (1984) found that challenging breathing exercises increased 
sympathetic arousal. Furthermore, a study of subjects with high trait anxiety characteristics 
revealed that rDSB without concentration on a pacing tone had a greater reduction of SCL 
compared with aDSB. The increase in SCL seen with aDSB in this study was associated with 
increased anxiety and muscle pain (Ozgocmen, Ozyurt, Sogut, & Akyol, 2006). Decreased 
sympathetic arousal and pain perception in response to DSB may be a result of downregulation 
in stress activity (Craig, 2003). This may be due to increased vagal tone and parasympathetic 
nervous system activity (Chalaye et al., 2009; Chandla et al., 2013). 
Vagal tone and parasympathetic nervous system activity. Increased vagal activity is 
hypothesized to decrease pain perception. The vagus nerve is the tenth cranial nerve, nuclei 
located in the medulla oblongata. The vagus nerve constitutes an important part of the 
parasympathetic autonomic nervous system. The vagus nerve is connected to regions of the brain 
controlling the autonomic nervous system, emotions, memory, and social behaviors (Snell, 
2001). Homeostasis of most of the body's systems that operate on a subconscious level is 
regulated by the vagus nerve. Vagal activity is usually continuous and passive and is used an 
indicator of parasympathetic nervous system activity. Vagal tone cannot be directly measured so 
other measures are used to represent vagal activity. Increased vagal tone slows the heart rate and 
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increases heart rate variability. Respiratory sinus arrhythmia (RSA) is a variation in heart rate 
during the breathing cycle. During RSA, inhalation restrains vagal activity which increases heart 
rate. Exhalation causes heart rate to decrease and vagal activity to resume. Since vagal tone 
cannot be directly measured, heart rate variability (HRV) is used to denote vagal activity 
(Chalaye et al., 2009). 
Vagal activity is directly related to breathing. During inspiration, stretch receptors in the 
lungs are stimulated. This produces a signal which is carried by vagal type C fibers through the 
nucleus tractus solitarius (NTS) to the hypothalamus. It is hypothesized that different impulse 
patterns produced by the vagus nerve during breathing affect the hypothalamus which controls 
autonomic balance. Increased vagal activity also inhibits the sympathetic vasomotor area in the 
medulla and may affect other brainstem and medullary nuclei that influence autonomic activity 
(Ganong, 2005). Corticospinal tracts controlling respiration also affect autonomic activity (Snell, 
2001). These circuits may work together to decrease sympathetic activity and increase 
parasympathetic activity (Chandla et al., 2013). 
The hypothesis that DSB increases vagal activity is supported by the findings of Chalaye 
et al. (2009). Mean standard deviation of the N-N interval (SDNN) was used as a general 
measure of HRV and the peak-to-valley index was used to measure breathing-induced 
oscillations in heart rate (HR) which is dependent on efferent vagal activity. Mean SDNN values 
rose significantly from baseline (52.1 ms) to 99.8 ms (p<0.05) following DSB and to 96.4 ms 
(p<0.05) following HR biofeedback. SDNN values decreased following rapid breathing and 
distraction conditions although results for these conditions were not statistically significant. 
Mean peak-to-valley amplitudes increased from baseline (0.099, p<0.05) following DSB (0.296, 
p <0.05) and HR biofeedback (0.288, p<0.05). Rapid breathing and distraction conditions 
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resulted in decreased peak-to-valley amplitudes. The rise in SDNN and peak-to-valley amplitude 
following DSB and HR biofeedback conditions indicate increased vagal activity. 
HF power is another measure of vagal activity. HF power was not significantly altered 
with any of the breathing conditions. Counterintuitively, LF power increased significantly from 
baseline (1,524 ms2) to 9,194 ms2 (p<0.05) following DSB and 8,463 ms2 (p<0.05) following HR 
biofeedback (Chalaye et al., 2009). The interpretation of LF is often disputed. While some 
consider LF power a measure of sympathetic activity, others consider LF power a measure of 
both sympathetic and vagal activity. Some suggest that as total power spectral density (PSD) 
increases, both LF and HF may increase (Malik et al., 1996). Chalaye et al. (2009) suggest that 
LF power increased with DSB and HR biofeedback as a result of overlap of RSA-associated 
oscillations and slow HR oscillations. Research is somewhat unclear on the interpretation of LF 
power relating to autonomic activity. 
Chandla et al. (2012) also evaluated the effects of DSB by examining the use of 
pranayama, a word meaning "extension of the prana or breath." Previous studies revealed that 
practicing slow breathing pranayama for three months resulted in increased parasympathetic 
activity and decreased sympathetic activity (Pal, Velkumary, & Madanmohan, 2004). Chandla et 
al. found that six weeks of slow breathing increased vagal parasympathetic tone. This was seen 
in the decrease in LF from baseline (76.93 nu) to 50.88 nu (p<0.001) and the increase in HF from 
baseline (49.26 nu) to 64.60 nu (p<0.001) following six weeks of pranayama. The LF/HF (power 
%) ratio also decreased from 4.67 (baseline) to 1.58 (p<0.001). These findings are much clearer, 
suggesting decreased sympathetic activity and increased vagal activity. Pal et al. reported similar 
findings in increased vagal tone after DSB exercises. Snell (2001) reported that DSB also 
increased thoracic pressure, venous return, and systolic blood pressure. Changes in blood 
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pressure are sensed by baroreceptors that send signals to the NTS. The NTS then sends 
excitatory signals to the nucleus ambiguous which control parasympathetic activity. The NTS is 
connected with the lateral parabrachial nucleus, ventrolateral medulla, and PAG, and involved in 
nociception (S. Telles & Desiraju, 1991). Activation of the baroreceptors also produces 
excitatory effects on NTS pain inhibitory relays (Ganong, 2005). 
Autonomic alterations due to tissue oxygenation. Although autonomic nervous system 
alterations in response to DSB are seemingly due to increased vagal tone, some studies suggest 
that changes are due to increased tissue oxygenation. However, there is currently little research 
to support this claim. Increased tissue oxygenation was seen with DSB, but not with rapid 
breathing. Researchers suggest that this increase in oxygenation with DSB could explain 
alterations in autonomic function (Pal et al., 2004; S. Telles & Desiraju, 1991). In addition, 
pranayama reduced oxygen consumption per unit work with time (Raju et al., 1994) and reduced 
oxidative stress levels. Increased superoxide dismutase levels and a decrease in the number of 
free radicals were also observed with pranayama practice. These results have long-term benefits 
and may explain the cardiopulmonary benefits associated with pranayama (Bhattacharya, 
Pandey, & Verma, 2002). In a study of Himalayan high altitude subjects, deep breathing 
exercises increased arterial oxygen saturation irrespective of age, gender, or altitude. However, 
the results of this research are questionable since raw data is only given for hematocrit levels 
(Nepal et al., 2013). Although the research on this aspect of DSB is limited, this may be an 
important part of how DSB influences the autonomic nervous system and reduces pain. 
Pulmonary function, carbon dioxide and pH. DSB may alter acid/base balance in the 
body by improving buffering capacity and pulmonary function. Buteyko breathing is a special 
form of DSB, based on the theories of Dr. Konstantin Buteyko. Buteyko hypothesizes that many 
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chronic diseases result from hyperventilation, resulting in carbon dioxide deficiency and 
metabolic disequilibria. Carbon dioxide is important for many physiological functions such as 
maintaining acid/base balance, dissociation of oxygen, and many chemical reactions. Buteyko 
breathing techniques include reduced-volume breathing, slow breathing, breath-holding 
techniques, and nasal breathing. Emphasis is put on the expiration phase of respiration and 
breath-holding pauses following expiration (Chaitow et al., 2014). 
Buteyko theorizes that deep slow breathing followed by a pause increases carbon dioxide 
in the blood and enhances the body’s buffering capacity. This, in turn, affects pH which is 
related to chronic diseases such as OA (Chaitow et al., 2014). This theory is supported by 
research demonstrating that the expiratory pause decreases minute ventilation which corresponds 
with carbon dioxide concentration in the alveolar air (Cooper et al., 2003). In addition, Buteyko 
breathing may increase forced expiratory volume (FEV1.0), a predictor of mortality (Menezes et 
al., 2014) and morbidity (Varela et al., 2007). 
Buteyko breathing has mainly been studied in those with pulmonary diseases and has not 
been studied in OA. Despite the lack of research on Buteyko breathing as an intervention for 
diseases such as OA, parts of this model may be incorporated into a breathing program for those 
with OA. The emphasis on expiration and the pause following expiration may be beneficial for 
improving buffering capacity which alters pain perception (Chaitow et al., 2014). 
 
Summary 
Although there is no research examining the effects of DSB as an intervention for OA, 
evidence suggests that DSB would be beneficial and effective. It is likely that DSB would 
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alleviate OA pain by increasing the pain threshold, altering autonomic activity, increasing 
oxygen saturation, decreasing reactive oxygen species involved in pain signaling, and altering 
acid/base metabolism (Busch et al., 2012; Chaitow et al., 2014; Nepal et al., 2013).  
Further research is needed in order to examine the effects of DSB on pain and 
functionality in those with OA. The WOMAC may be used to evaluate changes in pain and 
functional limits in subjects with hip or knee OA following DSB training (Bellamy et al., 1988). 
Results from this research may provide novel OA management approaches that are cost effective 
















Methods and Procedures 
Introduction 
This study was designed to examine the effect of a six week deep slow breathing (DSB) 
program on pain perception and heart rate variability (HRV) in subjects with lower extremity 
joint pain. This study provided information about the role of breathing in the management of 
joint pain. Novel and non-invasive management for joint pain is needed to decrease pain and 
improve function in those suffering from the disease. 
 
Description of Study Population 
Twenty subjects participated in the study. Subjects had been diagnosed by their physician 
with lower extremity osteoarthritis (OA) or had received a normative score of less than 50 on the 
American Academy of Orthopaedic Surgeons (AAOS) Hip and Knee Questionnaire. Subjects 
were recruited from the Bellingham Senior Activity Center and Western Washington University 
in Bellingham, WA and the Blaine Senior Center in Blaine, WA, following approval of the study 
from the University Human Subjects' Committee. Posters with information about the study were 
displayed at the senior centers and in the monthly newsletters, and sent directly to university 
students who knew the primary researcher and were interested in participating in the study. 
Subjects with unilateral joint pain had no history of joint replacement surgery. Subjects with 
bilateral joint pain that had undergone joint replacement surgery on only one joint were allowed 
to participate in the study. The joint that had not been operated on was used for assessment with 
the WOMAC. For subjects with bilateral joint pain that had not undergone joint replacement 
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surgery, the extremity with more severe pain, determined by the WOMAC pain score, was used 
for WOMAC assessment. No subjects had undergone joint surgery within the last six months. 
All subjects obtained medical clearance from a physician to participate in the study. 
 
Design of the Study 
This study utilized a pretest-posttest experimental design in which subjects were assigned 
to either the control or training group based on their availability for training. Those who could 
meet the time commitment for the training group were assigned to the training group on a first 
come first serve basis. 
 
Instrumentation 
Heart rate variability (HRV) was measured using Biopac Systems MP1500 (Goleta, CA). 
Disposable adhesive electrodes were used for the subject-EKG interface and HRV measurements 
were taken with a standard 3-electrode, 1-lead EKG setup which examined lead II. A MP1500 
(BIOPAC Systems Inc., Goleta, CA) interfaced with a Pentium III computer was used. 
AcqKnowledge software (BIOPAC Systems Inc., Goleta, CA) was used for data recording, 
collection, and data reduction. 
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Visual 
Analog Scale (VAS) was used to measure pain and physical function before and after the study. 
Nutritionist Pro software (Redmond, WA) was used to measure caloric intake and the Bouchard 





Training protocol for all subjects. The study was conducted over a six week period. All 
subjects were instructed not to alter their diet or physical activity level during the study. Three 
day diet and three day physical activity logs were completed pre and post breathing intervention. 
These logs were used to verify that no substantial changes were made in diet or physical activity. 
A medication log was submitted before and after the study. Subjects were instructed to notify the 
instructor if they began a new pain medication during the course of the six week DSB training. If 
a subject began a new pain medication during the study, they were excluded from the study. The 
control group did not attend weekly breathing training sessions. 
Weekly breathing training. Breathing training took place at the Bellingham Senior 
Activity Center in Bellingham, WA. Subjects were instructed to wear comfortable and loose 
fitting clothes Weekly sessions lasted for 30 minutes. Subjects were divided into groups of 2-4 
subjects. During DSB training, all subjects sat upright on a chair with back support. Subjects 
were informed of the discomfort or “air hunger” they may experience during DSB training. 
Subjects were assured that they could take a break from the breathing exercises if they felt dizzy 
or out of breath.  
During the first twenty minutes of breathing training, a script or outline was used to guide 
subjects through the breathing exercises. A script was used during the first week and outlines 
were used for the remaining weeks so that the trainer could more easily monitor the subjects. The 
script and outlines were timed and all subjects received the same training. The main focus of the 
breathing exercises was on inhaling deeply, prolonging the exhalation, and performing the 
expiratory pause. Each week, subjects were given a focus topic in order to keep their interest in 
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the program. Weeks one and two focused on awareness of breathing, weeks three and four 
focused on relaxation and tension release, and weeks five and six focused on breathing control. 
Specific parameters for controlling depth and frequency of breathing were not used in 
this study. The goal of the breathing exercises was to increase the depth and decrease the 
frequency of respiration from initial values for each individual. The expiratory pause aided 
subjects in reducing breath frequency. The remaining ten minutes of training was used to record 
respiratory rate and expiratory pause for each subject. 
Respiratory rate was measured by counting the number of times the chest or abdomen 
inflated and deflated in one minute. Subjects performed the expiratory pause following normal 
inhalation and exhalation. Following exhalation, subjects plugged their nose with their fingers 
and closed their mouth. This was held until the subject felt the very first urge to inhale. The 
amount of time that a subject could hold this pause was recorded as the expiratory pause 
(Chaitow et al., 2014). The data obtained were used for developing the training program and 
were not used for biofeedback. 
At-home breathing protocol. DSB subjects were instructed to complete the DSB 
exercises with the expiratory pause at home five days a week, 20-30 minutes a day (Chaitow et 
al., 2014). DSB subjects were given written instructions and a link to an instructional YouTube 
video on the expiratory pause (see appendix) to help them practice during the week. DSB 
subjects were educated on the importance of relaxation during DSB and instructed not to 
complete the breathing exercises while doing an attentive task such as reading, watching TV, 
conversing with family, or other tasks. Subjects were instructed to do the breathing exercises in a 
quiet room in an upright, seated position on a chair with back support. Both feet were to be 
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placed on the floor. On the day of the weekly group training session, subjects were not required 
to complete additional DSB at home.  
If subjects missed a weekly training session at the Bellingham Senior Center, they were 
required to make up the session on another day with the trainer. Subjects kept a breathing log and 
returned the log to the trainer each week to ensure compliance with the study. 
 
Measurement Techniques and Procedures 
The WOMAC was used to measure pain (five items) and physical function (17 items). 
Responses were based on the 1-100 mm visual analog scale. Responses were scored using a ruler 
to measure the distance in millimeters from the left end to the subjects pencil mark. Scores for 
each item were summed to obtain scores for each category: pain and physical function. Higher 
scores indicated worse pain and physical function. 
For HRV assessment, subjects were instructed to lie still on an examination table in the 
laboratory for five minutes. The laboratory was kept quiet and at a comfortable temperature. 
Alcohol swabs were used to prep the skin for optimal EKG signal acquisition. Three electrodes 
were configured to examine one lead. Wires were color coded white (right arm [RA]), black 
(right leg [RL]), and red (left leg [LL]) and were attached at the terminal ends to adhesive 
electrodes. Proximal ends of the wires were inserted into the EKG port of the MP1500 system. 
The electrodes attached to the RA, RL, and LL wires were placed on the anterior aspect of the 
right wrist, and medial aspects of the right and left ankles, respectively. The RA wire represented 
the negative aspect, the LL wire represented the positive aspect, and the RL wire was used as the 
ground for lead II. 
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The experimenter observed the EKG for line noise or unusual rhythms during data 
collection. The AcqKnowledge software recorded HRV data through EKG for five minutes. The 
subject was instructed to close their eyes and remain still and relaxed during the measurement. 
The data collection was terminated and started over if the subject talked or moved during 
collection. Once HRV data was collected, data was saved on the computer hard drive and the 
electrodes were removed from the subject. 
HRV variables were obtained from the raw EKG data using AcqKnowledge software 
which used algorithms following the frequency domain guidelines established by the Task Force 
of the European Society of Cardiology and The North American Society of Pacing and 
Electrophysiology (Task Force) (BIOPAC 2007; Malik et al., 1996). Power frequency for HRV 
variables were defined by Task Force guidelines as very low frequency (VLF), ≤ 0.04 Hz, low 
frequency (LF), 0.04-0.15 Hz, high frequency (HF), 0.15-0.4 Hz, and very high frequency 
(VHF), ≥ 0.4 Hz (Malik et al., 1996). LF to HF ratio (LF/HF ratio) was calculated from the data 
using AcqKnowledge software. 
The expiratory pause was measured using a SportLine 220 stopwatch. Subjects were 
taught to perform the expiratory pause by closing their eyes and inhaling and exhaling as usual. 
Following exhalation, subjects were instructed to close their mouth, plug their nose, and hold this 
until they felt the very first urge to breathe. At the very first urge to breathe, subjects were 
instructed to release from plugging their nose and resume breathing. The expiratory pause was 
recorded with the stopwatch from the time the subject plugged their nose to the time at which 
they released or inhaled, whichever occurred first. Subjects were allowed to practice the 
expiratory pause 1-2 times before the pause was recorded. The expiratory pause was then 




Data were collected prior to and following the six week DSB program. Data were 
collected at the same time period for both the control and experimental groups. WOMAC scores, 
HRV, and expiratory pauses were obtained and recorded. Post-test data were collected 48 hours 
after the end of the DSB program. 
 
Data Analysis 
Analysis was separated into three facets: subjective assessment using WOMAC scores 
(pain and physical), objective assessment using HRV variables (LF, HF, and LF to HF ratio), and 
evaluation of the training program using the expiratory pause. Means and standard deviations for 
pre- and post-intervention were calculated for variables within each facet and compared. Change 
scores were calculated for each variable by subtracting the pre-intervention measurement from 
the post-intervention measurement. Means and standard deviations were calculated and reported 
for the change scores. Pain and physical function were each analyzed using a mixed ANOVA. 
LF, HF, and LF/HF ratio were each analyzed using a mixed ANOVA. The expiratory pause was 
analyzed using a mixed ANOVA. Change scores were analyzed using a one-way ANOVA. 
Caloric intake and energy expenditure were analyzed using two tailed t tests. The alpha level for 
analysis was set at less than 0.05. A Bonferroni correction was applied for WOMAC and HRV 
facets (p = 0.025 and p = 0.017, respectively). Statistical analysis was used to evaluate if there 
was an interaction between group and time or a main effect for group or time. Data analysis was 





Results and Discussion 
 
Introduction 
This study tested the null hypothesis that six weeks of deep slow breathing (DSB) 
exercises would not result in significant differences in WOMAC Index scores (pain and physical 
function), heart rate variability (LF, HF, and LF/HF ratio), and expiratory pause from pre-test to 
post-test between control subjects and subjects that received training. Each subject attended two 
data collections approximately six weeks apart. Pain and physical function were assessed with 
the WOMAC Visual Analog Scale (VAS) 3.0. Autonomic nervous system activity was assessed 
with heart rate variability, specifically low frequency and high frequency components and 
sympathetic/vagal ratio. The expiratory pause was measured to determine any differences pre- 
and post-test for control and training subjects. 
 
Results 
 Subject characteristics. Twenty subjects (14 female, 6 male), aged 20-82 (67 ± 9) years 
old, participated in this study. Subjects had been diagnosed with osteoarthritis of their hip, knee, 
or ankle (n=13) or received a normative score of less than 50 on the American Academy of 
Orthopaedic Surgeons (AAOS) Hip and Knee Questionnaire (n=7). Subjects received physician 
clearance to participate and had not undergone surgery during the six months prior to the study. 





Table 1. Subject characteristics [mean ± standard deviation (SD)]. 
Subject Characteristics 
 Training (n=10) Control (n=10) 
Age (years) 67 ± 9 48 ± 19 
Height (m) 1.6 ± 0.1 1.7 ± 0.1 
Weight (kg) 70.5 ± 13.6 73.8 ± 13.4 
 
Subjective outcomes: WOMAC VAS pain and physical function. For WOMAC pain 
scores, there was not a significant interaction between group and time (F[1, 18] = 1.843, p = 
0.191, ηp
2 = 0.093) and there was not a significant main effect for group (F[1, 18] = 0.058, p = 
0.812, ηp
2 = 0.003). There was a significant main effect for time (F[1, 18] = 14.960, p = 0.001) 
and the effect size was large (ηp
2 = 0.454). For WOMAC physical function scores, there was not 
a significant interaction between group and time (F[1, 18] = 0.038, p = 0.848, ηp
2 = 0.002) and 
there was not a significant main effect for group (F[1, 18] = 0.038 , p = 0.671, ηp
2 = 0.010). 
There was a significant main effect for time (F[1, 18] = 18.425, p < 0.001) and the effect size 
was large (ηp
2 = 0.506). Means and standard deviations for pain and physical function are 















Table 2. WOMAC pain and physical function scores (mean ± SD) for each group pre- and post-
test. 
Pain 
 Pre-test Post-test 
Training 148 ± 94 84 ± 89 
Control 123 ± 87 92 ± 73 
Physical Function 
 Pre-test Post-test 
Training 434 ± 268 276 ± 287 
Control 482 ± 346 338 ± 274 
 



























Figure 2. A graphical representation of mean WOMAC VAS physical function scores for each 
group pre- and post-test. 
 
 
The change scores indicated that pain and physical function scores decreased for both 
training and control groups, but the changes were not statistically significant. Higher WOMAC 
scores indicate worse pain and physical function. The decreases in pain and physical function 
scores signify decreases in pain and improvements in physical function. Changes scores were not 
statistically significant for pain (F[1, 18] = 1.843, p = 0.191, ηp
2 = 0.093) or physical function 
(F[1, 18] = 0.038, p = 0.848, ηp
2 = 0.002). Means and standard deviations for pain and physical 






























WOMAC VAS Physical Function Scores Before and 





Table 3. Change in WOMAC pain and physical function scores (mean ± SD) for each group pre- 
and post-test.  
Change in WOMAC Scores 
 Pain Physical Function 
Training -64 ± 69 -158 ± 160 
Control -31 ± 34 -144 ± 155 
 









































Figure 4. A graphical representation of change in WOMAC physical function scores from pre- to 
post-test for each group. 
 
 
Objective outcomes: LF power, HF power, and LF/HF ratio. Analysis was conducted 
using data from ten training subjects and nine control subjects because data for one of the control 
subjects was not usable. Means and standard deviations for LF power, HF power, and LF/HF 
ratio are presented in Table 4 and Figures 5-7. For LF power, there was not a significant 
interaction between group and time (F[1, 17] = 0.526, p = 0.478, ηp
2 = 0.030). There was not a 
significant main effect for group (F[1, 17] = 0.690, p = 0.418, ηp
2 = 0.039) and there was not a 
significant main effect for time (F[1, 17] = 1.112, p = 0.306, ηp
2 = 0.061). Due to the large 
standard deviation in pre- and post-intervention measurements, a secondary axis was added to 
the graph displaying LF power before and following DSB (Figure 5). 
For HF power, there was not a significant interaction between group and time (F[1, 17] = 
0.005, p = 0.945, ηp




































0.687, p = 0.419, ηp
2 = 0.039) and there was not a significant main effect for time (F[1, 17] = 
0.693, p = 0.417, ηp
2 = 0.039) (Figure 6). 
For LF/HF ratio, there was not a significant interaction between group and time (F[1, 17] 
= 0.627, p = 0.439, ηp
2 = 0.036). There was not a significant main effect for group (F[1, 17] = 
0.627, p = 0.439, ηp
2 = 0.036) and there was not a significant main effect for time (F[1, 17] = 
3.464, p = 0.080, ηp
2 = 0.169) (Figure 7). 
 
Table 4. Heart rate variability: Low frequency power, high frequency power, and 
sympathetic/vagal ratio (mean ± SD) for each group pre- and post-test. 
Low Frequency Power (ms2) 
 Pre-test Post-test 
Training 179.30 ± 562.1 9.82 ± 28.84 
Control 32.08 ± 66.55 0.74 ± 0.73 
High Frequency Power (ms2) 
 Pre-test Post-test 
Training 14.04 ± 39.76 7.02 ± 19.24 
Control 7.43 ± 9.99 1.50 ± 1.87 
Sympathetic/Vagal Ratio 
 Pre-test Post-test 
Training 5.64 ± 10.03 2.13 ± 3.72 






Figure 5. A graphical representation of the low frequency (LF) power for each group pre- and 
post-test. This figure includes a secondary axis for the post-test LF power because of the large 
standard deviation of the post-test data in the training group. 
 
 





















































































Change scores for HRV indicate that there were no significant differences between the 
training and control groups. Change scores were not statistically significant for LF power (F[1, 
17] = 0.526, p = 0.478, ηp
2 = 0.030), HF power (F[1, 17] = 0.005, p = 0.945, ηp
2 = 0.000), or 
LF/HF ratio (F[1, 17] = 0.627, p = 0.439, ηp
2 = 0.036). Means and standard deviations for HRV 
change scores are presented in Table 5 and Figures 8-10. 
 
Table 5. Change in LF power, HF power, and LF/HF ratio scores (mean ± SD) for each group 
pre- and post-test.  
Change in HRV Scores 
 LF Power (ms2) HF Power (ms2) LF/HF Ratio 
Training -169.57 ± 566.52 -7.02 ± 45.78 -3.51 ± 6.93 
































Figure 8. A graphical representation of change in LF power from pre- to post-test for each group. 
 
 































































Training outcomes: Expiratory pause. Expiratory pause values were similar for 
training and control groups. There was not a significant interaction between group and time (F[1, 
18] = 0.307, p = 0.586, ηp
2 = 0.017). There was not a significant main effect for group (F[1, 18] 
= 0.686, p = 0.418, ηp
2 = 0.037) and there was not a significant main effect for time (F[1, 18] = 
0.111, p = 0.743, ηp
2 = 0.006). Means and standard deviations for the expiratory pause are 































Table 6. Expiratory pause (mean ± SD) for each group pre- and post-test. 
Expiratory Pause(s) 
 Pre-test Post-test 
Training 21 ± 12 23 ± 9 
Control 26 ± 10 25 ± 8 
 
Figure 11. A graphical representation of the expiratory pause for each group pre- and post-test. 
 
 
Change scores were not statistically significant for the expiratory pause (F[1, 18] = 0.336, 
p = 0.569, ηp
































Table 7. Change in expiratory pause scores (mean ± SD) for each group pre- and post-test.  








Subject compliance: Breathing, diet, and exercise logs. Nine of the ten training 
subjects completed all weekly breathing logs. The mean amount of time spent practicing DSB at 
home each week was 118 minutes with a standard deviation of 22 minutes. For the diet and 
exercise logs, eight training subjects and six control subjects completed the logs. The training 
group did not show significant changes in diet (p = 0.714) or exercise (p = 0.527) and the control 
group did not exhibit significant changes in diet (p = 0.448) or exercise (p = 0.497). Means and 


























Table 8. Diet and exercise (mean ± SD) measures for each group pre- and post-test. 
Diet (kcal in) 
 Pre-test Post-test 
Training 1794.61 ± 833.56 1730.06 ± 863.97 
Control 1884.74 ± 711.41 1942.42 ± 612.89 
Exercise (kcal out) 
 Pre-test Post-test 
Training 48.16 ± 6.60 49.05 ± 4.22 
Control 50.96 ± 11. 73 52.48 ± 14.45 
 
Discussion 
The purpose of this study was to evaluate the effects of a six week DSB exercise program 
on pain and physical function in subjects with lower extremity joint pain. The DSB exercise 
program was comprised of weekly practice sessions with a trainer and 20-30 minutes of DSB 
exercises at home, five days each week. The goal of the DSB exercise program was to lengthen 
the exhalation phase of breathing and the pause following exhalation. The null hypothesis stated 
that six weeks of DSB would not result in significant changes in WOMAC pain and physical 
function scores or HRV variables: LF power, HF power, and LF/HF ratio. 
Subjective outcomes: WOMAC VAS pain and physical function. Results from this 
study reveal that there was no significant interaction between group and time, and no significant 
differences between the training and control groups for WOMAC VAS pain and physical 
function scores. However, both training and control groups showed significant changes in pain 
and physical function scores from pre- to post-test assessments. Additionally, the mean changes 
in pain and physical function met the Minimal Clinically Important Improvement (MCII) criteria 
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(Tubach, 2005). However, the standard deviations for pain and physical function scores in both 
groups were very large and make it difficult to draw conclusions with regard to MCII criteria. 
Results indicate that while there were significant changes in pain and physical function scores, 
these changes did not result from the DSB exercise program. Alternatively, the changes in pain 
and physical function from pre- to post-test are likely due to another variable affecting both 
training and control groups. It is possible that subjects benefited from the social support they 
received while participating in the study. 
Social support may play an important role in improving pain and physical function for 
those suffering with OA (Escobar et al., 2007; Ethgen et al., 2004; Ferreira & Sherman, 2007; 
López-Martínez, Esteve-Zarazaga, & Ramírez-Maestre, 2008; Sharma et al., 2003). In studies 
evaluating the relationship between social support and OA outcomes, social support protected 
subjects against poor WOMAC outcomes (Sharma et al., 2003) and was associated with higher 
physical functioning, general health, mental health, social functioning, and vitality (Ethgen et al., 
2004). In addition to social support, optimism may help to mediate pain. Ferreira and Sherman 
(2007) investigated the role of social support in well-being and found that social support partially 
mediated pain perceptions in relation to depressive symptoms while optimism partially mediated 
pain perceptions in relation to life satisfaction. Both social support and optimism seem to be 
important mediators of OA pain. 
The importance of social support offers an explanation for the significant decrease in pain 
and improvement in physical function seen in both groups in the present study. Results of the 
present study combined with previous research highlight the potential importance of 
psychosocial factors in the adjustment to chronic pain. These results provide support for a 
biopsychosocial model of pain. While the DSB exercise program was not sufficient to 
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significantly alter WOMAC pain and physical function scores, social support may have played a 
role in the improvements seen in both training and control groups. There is currently no research 
that evaluates the use of research as a dimension of social support. More research is needed to 
confirm the theory that participation in a research study may increase perceived social support 
and improve self-reported OA outcomes. 
Objective outcomes: LF power, HF power, and LF/HF ratio. Results from this study 
reveal that there were no significant interactions between group and time and no main effects for 
group or time with respect to LF power, HF power, and LF/HF ratio. These results support the 
null hypothesis that a six week DSB exercise program would not significantly alter HRV, an 
indicator of autonomic nervous system (ANS) activity. Results of the present study contrast 
previous studies which indicate that DSB decreased sympathetic autonomic nervous system (S-
ANS) activity (Busch et al., 2012; Chandla et al., 2013; Pal et al., 2004) and increased 
parasympathetic autonomic nervous system (P-ANS) activity (Chalaye et al., 2009; Chandla et 
al., 2013; Pal et al., 2004). 
Due to the strong relationship between pain and ANS activity (Busch et al., 2012; 
Chalaye et al., 2009), it is surprising that the significant changes in WOMAC pain scores in the 
present study were not accompanied by significant changes in ANS activity. However, pain was 
self-reported and subjective in the present study. Studies supporting the relationship between 
pain and ANS activity have objectively measured pain perception by measuring heat pain 
threshold and tolerance (Busch et al., 2012; Chalaye et al., 2009). Further research is needed to 
examine the relationship between self-reported pain and ANS activity. 
Discrepancies between the present study and other research may be due to the 
methodology. This study measured HRV within 48 hours of the last at-home breathing exercise 
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session. Subjects were allowed to breathe naturally during HRV recording. Most studies 
evaluating the effect of breathing on HRV use controlled breathing during HRV recording or 
measure HRV immediately after the DSB session (Busch et al., 2012; Chalaye et al., 2009). 
Chandla et al. (2013) studied the effects of a six week DSB program, using pranayama, and 
found significant increases in HF power and decreases in LF power and LF/HF ratio. However, 
they did not report the procedures used during HRV recording. It is unknown if subjects breathed 
naturally or used controlled breathing during HRV recording for this study.  
Breathing patterns during HRV recording may significantly impact HRV results. In a 
study of 24 healthy males, the effect of different breathing patterns on HRV was assessed. HRV 
and respiratory rate were recorded during several conditions: voluntary breathing at rest and 
metronome guided breathing at 0.1, 0.2, and 0.4 Hz during rest and cycling. Results indicated 
that the breathing pattern had a moderate effect on LF power (η2 = 0.125) and LF/HF ratio (η2 = 
0.082) and a strong effect on HF power (η2 = 0.204) (Weippert, Behrens, Rieger, Kumar, & 
Behrens, 2015). These results are supported by a study which suggests that changes in HRV at 
respiratory frequencies (0.15-0.5 Hz) may be due to respiration. This study also examined the 
effect of respiratory frequency on changes in LF power (Beda, Simpson, Carvalho, & Carvalho, 
2014). Beda et al. demonstrated that up to 79 percent of changes in the LF power could be 
predicted by respiratory parameters such as respiratory period, tidal volume, and the tidal volume 
power in the LF band (VLF,n). These results reveal the relationship between respiratory variability 
and HRV and suggest that it is important to measure and assess respiration with HRV.  
Along with respiratory rate, respiratory ratio may play a key role in altering HRV. In a 
study by Van Diest et al. (2014), subjects were instructed to breathe at 6 or 12 breaths per minute 
with an inhalation/exhalation (i/e) ratio of 0.42 or 2.33. The lower i/e ratio was associated with 
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an increase in HF power, but only for the slow breathing pattern (F[1,22] = 36.12, p < 0.025). 
Results of this study indicate that both the respiratory rate and i/e ratio are important modulators 
of HRV (Van Diest et al., 2014). Both of these variables should be measured and considered 
when interpreting HRV data. With breathing patterns such as high frequency yoga breathing and 
breathing awareness, that breathing-related changes in HRV may last for up to 15 minutes 
following the return to uncontrolled or natural breathing (Telles, Singh, & Balkrishna, 2011). 
Therefore, it may also be important to consider the breathing pattern of an individual before 
HRV data collection begins. 
The methods of Kulur, Haleagrahara, Adhikary, and Jeganathan (2009) may be an 
effective way of measuring the effects of a DSB program on HRV. Kulur et al. trained subjects 
to breathe at a rate of six respiratory cycles per minute, five seconds for inhalation and five 
seconds for exhalation, during HRV recording. During the intervention, subjects were trained 
with diaphragmatic breathing and follow-up recording was completed at three months and one 
year. This methodology would help control for the changes in autonomic activity caused by 
respiratory variability during HRV recording. 
Due to the influence of respiration on HRV (Beda et al., 2014; Shirley Telles et al., 2011; 
Van Diest et al., 2014), controlling for respiratory variability during pre- and post-intervention 
HRV data collection may provide a more accurate assessment of the effects of a breathing 
intervention on HRV. Previous research on the relationship of respiratory variability and HRV 
may partially explain the lack of significant changes in HRV in the present study. Furthermore, 
the large standard deviations seen in the training group may be the result of greater respiratory 
variability due to increased breathing awareness (Telles et al., 2011). More research is needed to 
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examine the effects of DSB programs on HRV, utilizing controlled breathing during HRV data 
collection. 
Training outcome: Expiratory pause and anecdotal outcomes. There was not a 
significant interaction between group and time and there were also no significant main effects for 
group or time for the expiratory pause. Results reveal that the DSB exercise did not effectively 
increase the expiratory pause. While there is anecdotal evidence that the expiratory pause may be 
increased through training (Chaitow et al., 2014), there is no scientific evidence supporting this 
claim. This may explain why there were no significant changes in the expiratory pause during the 
course of the study. More research is needed to determine if the expiratory pause can be 
increased and the amount of training and time needed to induce chances in the expiratory pause. 
In addition to measured outcomes of this study, anecdotal results were also recorded. 
While no control subjects reported perceived changes during the study, eight training subjects 
reported a decrease in their stress level and an increase in their perceived ability to effectively 
manage stress. Eight subjects reported that the breathing exercises helped them to cope with their 
joint pain, even when the pain did not subside following the DSB exercises. Eight training 
subjects reported increased awareness of both their breathing patterns and awareness of tension 
in their bodies. All training subjects reported being able to effectively release tension in their 
body and relax using the breathing exercises. Additionally, six subjects reported improved 
physical function, five subjects reported improved mood, three subjects reported decreased pain, 
and two subjects reported improved sleep quantity and quality. 
Limitations. Additional limitations of this study involve the lack of control for other 
variables such as age, body mass index, knee pain intensity, disease severity, and additional 
potential confounders. The small, non-random nature of the sample may have also affected the 
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results and limited the generalizability of the results. Additionally, the large standard deviations 
of all variables and the self-report nature of the WOMAC assessment of pain and physical 
function may have affected the results.  
 
Summary  
Six weeks of DSB did not significantly alter pain-related variables in subjects with lower 
extremity joint pain. However, both training and control groups experienced significant 
decreases in pain and significant improvements in physical function over the course of the study. 
Changes in pain and physical function from pre- to post-test appear to be the result of social 
support that subjects received by participating in the study. The lack of significant changes in 
HRV variables may have been due to the large standard deviations and the lack of breathing 
control during HRV data collection. Further research is needed as the present study is the first to 
evaluate the use of DSB as an intervention for arthritis-related pain and physical limitation. 
Additional research would also ideally identify subjects with arthritis who would benefit most 
from DSB and the amount of DSB needed to produce significant or minimal clinically important 











Summary, Conclusions, and Recommendations 
 
Summary 
Effective and novel interventions for arthritis-related symptoms are important as arthritis 
is the leading cause of disability among adults in the United States and current non-surgical 
interventions have low efficacy (CDC, 2013; Losina et al., 2014). Breathing exercises have been 
used for years in a clinical setting to reduce pain and improve health, especially in labor and 
delivery (Lothian, 2011). However, they have not been used as an intervention for OA.  Recent 
studies suggest that deep slow breathing (DSB) relieves pain (Chalaye et al., 2009) and improves 
mood (Busch et al., 2012). DSB reduces pain in healthy subjects by increasing pain threshold, 
increasing parasympathetic activity (Chalaye et al., 2009), decreasing sympathetic activity 
(Busch et al., 2012), and altering pCO2 and pH (Chaitow et al., 2014). Breathing also improves 
mood, which would improve depressive symptoms associated with arthritis (Busch et al., 2012). 
As the prevalence of arthritis rises (CDC, 2013), cost-effective interventions that target 
pain are highly valuable. The role of DSB in improving joint pain has not previously been 
studied. DSB may be an effective method for improving pain, function, and mood. This model 
may be especially appealing to patients with arthritis because the time commitment and cost are 
less than traditional therapeutic measures, DSB puts no mechanical stress on the joints, and DSB 
may be relaxing for those with OA. As symptoms improve with the use of DSB, those with 
arthritis may be more likely to participate in other physical activities, resulting in further health 
benefits. The purpose of this study was to determine if a significant difference existed in joint 
pain perception and heart rate variability (HRV) following a six week DSB exercise program. A 
58 
 
better understanding of the effects and mechanisms of DSB may provide novel and practical 
approaches to treating joint pain. 
 
Conclusions 
The results of this study indicate that six weeks of DSB did not produce significant 
changes in pain, physical function, LF power, HF power, or LF/HF ratio. However, both training 
and control groups exhibited significant changes in WOMAC pain and physical function scores 
from pre- to post-intervention. These changes may have been due to an increased perception of 
social support during participation in the study. The lack of significant differences in HRV 
parameters may be due to the lack of breathing control during HRV data collection. The absence 
of breathing control may have also resulted in the large standard deviations seen in the HRV 
data. This is the first study to examine the efficacy of DSB as an intervention for joint pain and 
physical limitation. Furthermore, research on DSB as an intervention for chronic pain is limited. 




Future research. The current study is the first to investigate the efficacy of DSB as an 
intervention for lower extremity joint pain and functional limitations. Further research is needed 
to investigate the efficacy of DSB and to determine the type and dosage of DSB needed to 
produce significant changes in pain and physical function. Part of the difficulty in studying pain 
is the measurement. Pain is usually assessed by pain scales, questionnaires, or measurements of 
pain threshold (Busch et al., 2012; Chalaye et al., 2009; Chambers et al., 2009). However, there 
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is some research that suggests that certain areas of the brain become active when a person 
experiences pain. This network is known as the “pain matrix” (Kulkarni et al., 2007). Future 
studies should utilize functional magnetic resonance imaging (fMRI) to assess the changes in 
activity of the pain matrix during DSB exercises. In order to effectively study the pain matrix, 
however, subjects would need to be in pain when the imaging began and complete the DSB 
exercises while experiencing pain. This type of study would assist researchers in determining the 
amount of DSB that is needed to decrease pain. 
Due to the relationship between respiratory variability and HRV, future studies utilizing 
HRV to evaluate autonomic nervous system (ANS) activity should measure, assess, and consider 
respiratory variability during HRV data collection. Additionally, research is needed to determine 
if the effects of DSB on HRV are acute or produce lasting changes. If the changes in HRV 
persist, research is needed to determine the length of time that changes in HRV persist. 
Respiratory parameters such as respiratory rate and depth, forced expiratory volume in one 
second (FEV1.0), minute ventilation (MVV), and diaphragmatic excursion would also provide 
more information about possible mechanisms of action and help determine how DSB alters 
respiratory physiology. 
Results of this study may also underscore the role of social support in mediating pain and 
physical limitations. To date, studies have examined social support using questionnaires, self-
reported measurements, or marital and living status (Ethgen et al., 2003; Escobar et al., 2006; 
Sharma et al., 2003). There are no studies evaluating the use of club activities, support groups, or 
participation in research as an intervention for arthritis. Future studies should investigate the role 




This study may be used to develop future studies that further probe the use of DSB as an 
intervention for joint pain and dysfunction. Further research will provide more information about 
the role of DSB as an intervention for joint pain. A better understanding of the effects and 
mechanisms of DSB may provide novel and practical approaches to treating joint pain. 
Practical applications. At this time, DSB does not appear to produce significant changes 
in OA joint pain or physical function. Anecdotal evidence from this study, however, indicates 
that DSB may help those with arthritis to cope with pain by reducing stress and increasing 
awareness of tension and breathing patterns. Although the purpose of this study was not to 
examine the effect of social support on pain-related symptoms, this study highlights the potential 
role of support as a mediator of pain and functional limitations and provides support for a 
biopsychosocial model of pain. Club activities or support groups may be beneficial for those 
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Human Subjects Activity Review 
1. What is your research question, or the specific hypothesis? 
This study examines the effects of a six week deep slow breathing program on 
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index scores, 
heart rate variability (HRV), and expiratory pause in subjects with osteoarthritis (OA) of 
the hip and knee. 
 
2. What are the potential benefits of the proposed research to the field? 
The proposed research will investigate the efficacy of a breathing program for 
those suffering with arthritis. Arthritis is the leading cause of disability among adults in 
the United States, affecting an estimated 50 percent of people age 65 and older. The 
disease costs the United States approximately 128 billion dollars in medical care and lost 
wages annually and is associated with other health disorders such as diabetes, 
hypertension, obesity, and cancer. Furthermore, half of those with arthritis also suffer 
from cardiovascular disease, the leading cause of death among both men and women in 
the United States (Centers for Disease Control and Prevention (CDC), 2013). 
OA is the most common form of arthritis, mainly affecting the hands, hips, and 
knees. Those suffering from OA experience a great deal of pain, limiting physical activity 
and decreasing quality of life. Fear of pain or worsening symptoms may discourage those 
with OA from beneficial exercise, leading to other health problems associated with OA 
(CDC, 2013). Because pain is the major limiting factor for those with OA, most 
interventions are aimed at reducing pain. However, surgical intervention is expensive and 
non-surgical interventions have low efficacy (Losina et al., 2014). Some interventions, 
such as pain relievers, may produce other health complications, such as damage to the 
liver, kidneys, and gastrointestinal (GI) tract (Max & Stewart, 2008; Michael et al., 
2010). 
There is a need for effective non-surgical interventions. Exercise has been 
proposed as an effective and beneficial intervention for those with arthritis. Exercise 
reduces pain and improves function, quality of life, mood, and confidence to manage 
health (CDC, 2013). Despite the benefits of exercise, 60 percent of people suffering with 
the disease do not adhere to physical activity guidelines and 23 percent are categorized as 
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physically inactive. This decrease in physical activity (hypokinesis) in those with OA 
may be a result of pain or fear of worsening symptoms with exercise (Austin et al., 2012). 
Hypokinesis progresses OA by increasing stiffness and weakness in the joints and 
causing metabolic acidosis and chronic inflammation, making exercise even more 
challenging (Michael et al., 2010). 
Since aerobic and resistance training are effective non-surgical interventions but 
many with OA will not participate, alternative exercises must be evaluated. Breathing 
exercises have been used for years in a clinical setting to reduce pain and improve health, 
especially in labor and delivery (Lothian, 2011). However, they have not been applied as 
an intervention for OA. Respiration plays an important role in pain signaling and 
autonomic system activation, emotion regulation, acid/base balance, and anti-
inflammatory processes. Recent studies suggest the deep slow breathing relieves pain 
(Chalaye et al., 2009) and improves mood (Busch et al., 2012). Studies in healthy 
subjects reveal that deep slow breathing (DSB) reduces pain by increasing pain threshold, 
increasing parasympathetic activity (Chalaye et al., 2009), decreasing sympathetic 
activity (Busch et al., 2012), and altering pCO2 and pH (Chaitow et al., 2014). Breathing 
also improves mood, which would greatly impact those with OA since many suffer from 
depression as well (Busch et al., 2012). 
DSB has not been studied as an intervention for OA, but may be an effective 
method for improving pain, function, and mood. This exercise model may be appealing to 
patients with OA because the time commitment and cost are less than traditional 
therapeutic measures. In addition, DSB puts no mechanical stress on the joints and may 
be relaxing for those with OA. As symptoms improve with the use of DSB, those with 
OA may be more likely to participate in other physical activities, resulting in further 
health benefits. Results from this study will provide information about the role of DSB in 
relieving OA pain. A better understanding of the effects and mechanisms of DSB may 







3. What are the potential benefits, if any, of the proposed research to the subjects? 
This research may provide support for the use of deep slow breathing for pain 
alleviation. Subjects will receive deep slow breathing training and may use the techniques 
after the study if they are effective. 
 
4. A. Describe how you will identify the subject population, and how you will contact 
key individuals who will allow you access to that subject population or database. 
Participants with OA, defined by the Centers for Disease Control and Prevention 
(2013), will be recruited from the Arthritis Foundation, Bellingham Senior Activity 
Center, and Blaine Senior Activity Center. The primary researcher currently volunteers at 
the Arthritis Foundation and will teach a class on dealing with OA pain. At the end of the 
class, the primary researcher will recruit subjects for this study. The primary researcher 
will also recruit subjects at Arthritis Foundation events as well as distribute posters. The 
researcher will also recruit subjects at the Senior Activity Centers in Bellingham and 
Blaine, WA. Managers from the Arthritis Foundation and Senior Activity Centers have 
given their consent for the primary researcher to recruit subjects through them. The 
consent forms are attached to this document. 
 
B. Describe how you will recruit a sample from your subject population, including 
possible use of compensation, and the number of subjects to be recruited. 
At least 30 subjects will be recruited for this study. Subjects must have physician-
diagnosed moderate to severe, unilateral or bilateral OA of the hip and/or knee joint(s). 
Subjects with unilateral OA must not have a history of joint replacement surgery. 
Subjects with bilateral OA who have undergone joint replacement surgery on only one 
joint will be allowed to participate. The joint that has not been operated on will be used 
for assessment with WOMAC. For subjects with bilateral OA that have not undergone 
joint replacement surgery, the extremity with more severe pain, determined by the 
WOMAC pain score, will be used for WOMAC assessment. No subjects will have 
undergone joint surgery within the last six months. All subjects will obtain medical 




5. Briefly describe the research methodology. Attach copies of all test 
instruments/questionnaires that will be used. 
Design of the study: This study will utilize a pretest-posttest randomized groups 
experimental design in which subjects will be randomly assigned to either the control or 
training group. Subjects will be randomly assigned to either the control or training group 
by drawing a piece of paper from a paper bag. Those who drew a paper with a “C” were 
assigned to the control group and those who drew a paper with a “T” were assigned to the 
training group. 
 
Instrumentation: Heart rate variability (HRV) will be measured using Biopac (Goleta, 
CA). Disposable adhesive electrodes will be used for the subject-EKG interface and HRV 
measurements will be taken with a standard 3-electrode, 1-lead EKG setup which 
examines lead II. An MP100 (BIOPAC Systems Inc., Goleta, CA) interfaced with a 
Pentium III computer will be used. AcqKnowledge software (BIOPAC Systems Inc., 
Goleta, CA) was used for data recording, collection, and data reduction. The Visual 
Analog Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index will 
be used to assess pain and physical function. Nutritionist Pro software (Redmond, WA) 
will be used to measure caloric intake and the Bouchard method will be used to 
determine energy expenditure (Bouchard et al., 1983) before and after the study. 
 
Experimental protocol: The study will be conducted over six weeks. All subjects will be 
instructed not to alter diet or physical activity. Three day diet and physical activity logs 
will be completed pre and post breathing intervention to verify that no substantial 
changes were made in diet or physical activity. Subjects will be instructed to notify the 
researcher if they begin a new medication. Subjects who begin new medications will be 
excluded from the study. The control group will not attend weekly breathing training. 
The training group will attend weekly breathing training. 
Breathing training will take place at Western Washington University, Bellingham 
Senior Activity Center, and Blaine Senior Activity Center. Subjects will be instructed to 
wear comfortable and loose fitting clothes. Weekly sessions will last for 30 minutes. 
Subjects will be divided into groups of 3-4 subjects. During breathing training, all 
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subjects will sit upright on a chair with back support. Subjects will be informed of the 
discomfort or “air hunger” they may experience during breathing exercises. Subjects will 
be assured that they may take a break if they feel dizzy or out of breath.  
During the first ten minutes of breathing training, subjects will be instructed to 
place one hand on their abdomen and one hand on their chest and focus on breathing at a 
slow and comfortable pace. Subjects will be instructed to inhale through their nose and 
exhale through their mouth. Once subjects are comfortable and focused on their 
breathing, ten minutes will be spent practicing the expiratory pause. Subjects will 
perform the expiratory pause following normal inhalation and exhalation. Following 
exhalation, subjects will plug their nose with their fingers and close their mouth. This will 
be held until the subject feels the urge to inhale. The amount of time that a subject can 
hold this pause will be recorded as the expiratory pause (Chaitow et al., 2014). 
Specific values for depth and frequency of breathing will not be used in this 
study. The expiratory pause will aid subjects in reducing breath frequency. The remaining 
ten minutes of training will be used to record breath frequency by counting the number of 
breaths per minute. Breathing frequency will be use to verify that the breathing training is 
decreasing breath frequency. 
Training subjects will also be instructed to complete the breathing exercise with 
the expiratory pause at home five days a week for 20-30 minutes each day (Chaitow et 
al., 2014). Subjects will keep a log of breathing exercises. Subjects will be given written 
instructions and a link to an instructional YouTube video produced by the researcher to 
help them practice during the week. On the day of the weekly group training session, 
subjects will not be required to complete additional breathing exercises at home. 
If subjects miss a weekly training session with the researcher, they will be 
required to make up the session on another day with the trainer. If subjects miss an at-
home session, they will be instructed to continue as usual the next day, without making 
up the missed session. If they miss more than three at home sessions, they will be 
excluded from the study. Training group subjects will be instructed not to complete 




Measurement techniques and procedures: Subjects will self-report their age and sex. 
Body height will be measured by the researcher using a stadiometer. Body weight will be 
measured using a medical scale.  
For HRV measurements, subjects will be instructed to lie on an examination table 
in the laboratory. Alcohol swabs will be used to prepare the skin for optimal EKG signal 
acquisition. Three electrodes will be configured to examine one lead. Wires will be color 
coded (right arm [RA]), black (right leg [RL]), and red (left leg [LL]) and equipped with 
clips at the terminal ends for placement of adhesive electrodes. Proximal ends of the 
wires will be inserted into the EKG port of the MP100 system. The electrodes attached to 
the RA, RL, and LL wires will be placed on the anterior aspect of the left wrist, and 
medial aspects of the right and left ankles, respectively. The RL wire will be used as the 
ground, the RA wire will represent the negative aspect, and the LL wire will represent the 
positive aspect of lead II. The experimenter will observe for line noise or unusual 
rhythms during data collection. The AcqKnowledge software will record HRV data 
through EKG for five minutes. The subjects will be instructed to remain still and relaxed 
during the measurement. Once HRV data is collected, data will be saved and the 
electrodes will be removed from the subject. HRV variables will be obtained from the 
raw EKG data using AcqKnowledge software (BIOPAC, Goleta, CA). 
Subjects will perform three timed trials of the expiratory pause. The longest time 
for these trials will be used for data analysis. The WOMAC will be used to measure pain 
(five items) and physical function (17 items). Responses will be based on the 1-100 mm 
visual analog scale. Responses will be scored using a ruler to measure the distance in 
millimeters from the left end to the subjects pencil mark. Scores for each item will be 
averaged to obtain average scores for each category: pain and physical function. Higher 
scores indicate worse pain and physical function. 
 
Data collection: Data will be collected prior to and following the six weeks of training or 
no training (control group). Data will be collected at the same time for both the control 
and training groups. HRV, WOMAC Index scores, and expiratory pause values will be 




Data analysis: Analysis will be separated into three facets: HRV, WOMAC Index 
scores, and expiratory pause. Diet (caloric intake) and exercise (energy expenditure) will 
be analyzed, additionally, to verify that no substantial changes were made to diet or 
exercise levels. Means and standard deviations pre and post intervention will be 
calculated for variables within each facet and compared pre and post. Each HRV variable 
(LF and LF/HF) will be analyzed using a two way ANOVA. WOMAC Index variables 
(pain and physical function) will each be analyzed using a two way ANOVA. Expiratory 
pause will also be analyzed using a two way ANOVA. Caloric intake and energy 
expenditure will be analyzed using two tailed t-tests. The alpha level for all analyses will 
be set at less than 0.05 with a Bonferroni correction applied for HRV variables and also 
separately for the WOMAC domains. Results will be compared between control and 
training groups. Data analysis will be completed with Excel (Microsoft Inc., Redmond, 
WA) and SPSS (Armonk, NY). 
 
6. Give specific examples (with literature citations) for the use of your test 
instruments/questionnaires, or similar ones, in previous similar studies in your field. 
No previous research has examined the effects of deep slow breathing on OA 
pain. Research examining the effects of deep slow breathing on pain in healthy 
individuals and those with cardiovascular disease revealed that deep slow breathing 
alleviated pain (Busch et al., 2012; Chalaye et al., 2009; Chandla et al., 2013). In order to 
examine the effect of deep slow breathing on OA pain, the WOMAC is a good indicator. 
The WOMAC is one of the most commonly used self-reported measures of lower 
extremity symptoms and function. It was specifically designed to evaluate pain, function, 
and stiffness in subjects with osteoarthritis of the hip and knee. The WOMAC has been 
studied for over 30 years in various contexts and in subjects of different ethnic 
backgrounds (McConnell et al., 2001). The WOMAC is supported as a valid and reliable 
measurement of pain and function in subjects with hip or knee osteoarthritis (Bellamy et 
al., 1988; Pua et al., 2009; Wolfe & Kong, 1999). 
DSB is hypothesized to improve pain in healthy individuals by increasing 
parasympathetic activity (Chalaye et al., 2009) and decreasing sympathetic activity 
(Busch et al., 2012). Many studies have found an increase in parasympathetic activity 
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(vagal tone) with deep slow breathing exercises (Chalaye et al., 2009; Chandla et al., 
2013; Pal et al., 2004). Since vagal tone cannot be directly measured, HRV is used to 
denote vagal activity (Chalaye et al., 2009). DSB-related changes in autonomic activity 
have not been measured in subjects with OA. 
Likewise, the expiratory pause has not been measured in subjects with OA. 
However, the expiratory pause has been studied in subjects with asthma. The control 
pause improves asthmatic symptoms, but does not change pulmonary function (Cooper et 
al., 2003). This study will provide more information about the role of DSB and the 
expiratory pause in alleviating pain and altering autonomic activity. 
 
7. Describe how your study design is appropriate to examine your question or specific 
hypothesis. Include a description of controls used, if any. 
This study is a pretest-posttest randomized groups experimental design in which 
subjects will be randomly assigned to either the control or training group. At least thirty 
volunteers will participate in the study. Deep slow breathing training will be compared 
pre and post. Results will be compared between the control and training groups. The 
control group will be used to verify that results in the training group are actually due to 
the breathing training. Diet and exercise journals will be used to verify that results are not 
due to substantial changes in diet or exercise. This study design is appropriate to examine 
the effect of a six week deep slow breathing program on HRV, WOMAC Index scores, 
and expiratory pause in subjects with OA of the hip and knee. Specifically, this design 
allows the researcher to compare differences in variables pre and post as well as between 
control and training groups. 
 
8. Give specific examples (with literature citation) for the use of your study design, or 
similar ones, in previous similar studies in your field. 
Many studies have used the pretest-posttest randomized groups experimental design to 
investigate the effects of deep slow breathing on pain-related variables such as pain 
threshold and pain tolerance (Busch et al., 2012; Chalaye et al., 2009). Surprisingly, very 
few studies have used a control group while studying the effects of deep slow breathing. 
Chandla et al. (2013) used a control group with the pretest-posttest randomized groups 
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experimental design and found a significant difference between the deep slow breathing 
(pranayama) group and the control group. Without a control group, it is difficult to 
conclude that results are due to breathing exercises rather than education or some other 
factor during the experiment. 
 
9. Describe the potential risks to the human subjects involved. 
As with any breath holding exercise, potential risks include feelings of breathlessness, 
“air hunger,” dizziness, and light headedness, and/or fainting. Discomfort during 
breathing exercises is expected, especially during the first training session. 
 
10. If the research involves potential risks, describe the safeguards that will be used to 
minimize such risks. 
Subjects will be informed of the discomfort or “air hunger” they may feel during the 
exercises. They will be instructed to notify the instructor if they feel any discomfort and 
they will be encouraged to take a break from the activity until they feel comfortable to 
participate again. The researcher will emphasize that the subjects are to hold their breath 
until the first urge to breathe and no longer than this urge. The subjects will perform all 
breathing exercises in a seated position in a chair with back support with their feet flat on 
the floor. This will help protect subjects from injury in the unlikely event that a subject 
passes out. The researcher and research assistants will carefully observe subjects to 
ensure that breathing exercises are being performed correctly and subjects are not holding 
their breath longer than they should. 
 
11. Describe how you will address privacy and/or confidentiality. 
All data collected will be kept completely confidential. The data will be stored on a 
password protected computer and stored separately from the signed consent forms.  Data 































The Effect of Deep Slow Breathing on Pain-Related Variables 
Physical Education, Health, and Recreation Department 
Western Washington University 
Informed Consent 
You are invited to participate in a research study conducted by Kalee Larsen, from the 
Department of Physical Education, Health, and Recreation at Western Washington University. 
This study involves research on the effects of deep slow breathing on pain-related variables. 
Deep slow breathing is often used to alleviate pain and improve physical function and mood. The 
effects of deep slow breathing on lower extremity joint pain have not been studied. The purpose 
of this research is to investigate the effects of a six week deep slow breathing program on lower 
extremity joint pain and function. 
Given your consent, you will be assigned to either the control group or the training group. 
Everyone will attend two testing sessions at Western Washington University: during week one 
and week eight of the study. If you are assigned to the control group, you will be asked not to 
alter your diet or physical activity level for the six week period between data collections. If you 
are assigned to the training group, you will be asked not to alter your diet or physical activity 
level and you will attend six weeks of deep slow breathing training at Bellingham Senior 
Activity Center or Blaine Senior Center. 
Testing sessions: Both sessions will involve the same procedures for control and training 
group subjects. You will be asked to complete the Western Ontario and McMaster Universities 
Osteoarthritis (WOMAC) Index, a questionnaire designed to evaluate joint pain and physical 
function. You will be asked to lie on an examination table for five minutes while heart rate 
variability (HRV) measurements are taken. For this measurement, electrodes will be placed on 
the skin of your right arm, right leg, and left leg and you will be required to be completely still 
while data is collected. This is the same procedure as a standard electrocardiogram (EKG), but a 
longer recording of six minutes is taken. You will be asked to complete an expiratory pause, 
performed by breathing in and breathing out then holding your breath until you feel the first urge 
to breathe. The researcher will measure how long you can hold this pause before you feel the 
first urge to breathe. The expiratory pause will be taken three times and the best time will be 
used for data analysis. In addition to these measurements, you will be asked to complete a three 
day diet and exercise log before each data collection. The researcher will provide you with the 
log to fill out and bring with you to each data collection. 
Breathing training sessions: If you are assigned to the training group, you will complete a 
six week deep slow breathing training program. You will attend weekly training sessions with 
the researcher at the Bellingham Senior Activity Center or Blaine Senior Center. You will also 
complete 20-30 minutes of deep slow breathing at home five days a week.  
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As with any breathing exercise, potential risks include feelings of breathlessness, “air 
hunger,” dizziness, light headedness, and/or fainting. If you experience any of these feelings, you 
should alert the researcher immediately. Discomfort during breathing exercises is expected, 
especially during the first training session. Supervision of breathing exercise is done to minimize 
the risk of injury or adverse effects. You may take a break from the exercise if you experience 
discomfort and you may withdraw from participation in this study at any time, without penalty. 
This study is potentially beneficial because it will provide information about the effects 
of deep slow breathing on joint pain. At the conclusion of the study, control subjects will be 
given the opportunity to be trained with the breathing techniques. 
Questions regarding this study and the procedures will be answered by the primary 
researcher, Kalee Larsen, who may be contacted at Kalee.Larsen@wwu.edu or 360-319-4350 or 
Dr. Lorrie Brilla, who may be contacted at Lorrie.Brilla@wwu.edu or 360-650-3056. 
Questions about your rights as a research subject should be directed to Janai Symons, the 
WWU Research Compliance Officer (RCO), at Janai.Symons@wwu.edu or 360-650-3082. If 
you experience injury or any adverse effect from this study, contact Kalee Larsen, Dr. Lorrie 
Brilla, or Janai Symons. 
All data collected will be kept completely confidential. The data will be stored on a 
password protected computer and external hard drive and stored separately from the signed 
consent forms. Data will be analyzed by subject number and only primary researchers will have 
access to the records. 
Your signature indicates that you have read and understand the information provided 
above, that you willingly agree to participate, that you may withdraw your consent at any time 
and discontinue participation without penalty, that you have received a copy of this form, and 
that you are not waiving any legal claims, rights, or remedies. Thank you for your participation 
in this study. 
 
__________________________________________________  _____/_____/_____ 

































PERMISSION FORM TO CONTACT SENIORS FOR TESTING 
 
Letter of permission: 
As the manager of the Arthritis Foundation, I, ___________________________, consent to 
allow Kalee Larsen to recruit subjects from the Arthritis Foundation for thesis research, which 
includes physiological measurements before and following a six week breathing intervention. 
 
__________________________________     _____/_____/_____ 




















PERMISSION FORM TO CONTACT SENIORS FOR TESTING 
 
Letter of permission: 
As the manager of the Bellingham Senior Activity Center, I, ___________________________, 
consent to allow Kalee Larsen to recruit members of the Bellingham Senior Activity Center for 
thesis research, which includes physiological measurements before and following a six week 
breathing intervention. 
 
__________________________________     _____/_____/_____ 



















PERMISSION FORM TO CONTACT SENIORS FOR TESTING 
 
Letter of permission: 
As the manager of the Blaine Senior Activity Center, I, ___________________________, 
consent to allow Kalee Larsen to recruit members of the Blaine Senior Activity Center for thesis 
research, which includes physiological measurements before and following a six week breathing 
intervention. 
 
__________________________________     _____/_____/_____ 












































Research Pre-Participation Packet 
 
Dear Participant, 
Thank you for volunteering for this study. This research will provide important 
information about how deep slow breathing exercises affect joint pain and physical function. 
Before we begin, the following forms must be completed and returned to Kalee Larsen, the 
primary researcher. 
 Study description 
 Informed consent 
 Physician clearance form 
 Health history form 
Please provide your physician with the study description, informed consent, and 
physician clearance form. Your physician will need to read the study description and informed 
consent before signing the physician clearance form. Please also read and sign the informed 
consent and fill out the health history form. This will help us to provide the safest conditions for 














This study examines the effects of a six week deep slow breathing program on pain and 
physical function in subjects with lower extremity joint pain. Subjects will be randomly assigned 
to either the control or training group. All subjects will attend two data collections at Western 
Washington University: one before and one after the six week period. Training subjects will also 
complete six weeks of deep slow breathing training. Training subjects will attend a weekly 
breathing training session at the Bellingham Senior Activity Center or Blaine Senior Center. 
Training subjects will also complete at-home breathing exercises for 20-30 minutes, five days a 
week. Breathing exercises will be performed while subjects are seated in a chair with back 
support with their feet flat on the floor. Breathing training will focus on prolonging the 
expiration and performing an expiratory pause. The expiratory pause is performed following 
normal inhalation and exhalation. Following exhalation, the subject will plug their nose and 
close their mouth. This will be held until the first urge to breathe. The amount of time a subject 
can hold this is defined as the expiratory pause. Pain and physical function will be measured 
before and after the study using the Western Ontario and McMaster Universities Osteoarthritis 
Index. Autonomic nervous system activity will be assessed with heart rate variability. The 














The Effect of Deep Slow Breathing on Pain-Related Variables 
Physical Education, Health, and Recreation Department 
Western Washington University 
Informed Consent 
You are invited to participate in a research study conducted by Kalee Larsen, from the 
Department of Physical Education, Health, and Recreation at Western Washington University. 
This study involves research on the effects of deep slow breathing on pain-related variables. 
Deep slow breathing is often used to alleviate pain and improve physical function and mood. The 
effects of deep slow breathing on lower extremity joint pain have not been studied. The purpose 
of this research is to investigate the effects of a six week deep slow breathing program on lower 
extremity joint pain and function. 
Given your consent, you will be assigned to either the control group or the training group. 
Everyone will attend two testing sessions at Western Washington University: during week one 
and week eight of the study. If you are assigned to the control group, you will be asked not to 
alter your diet or physical activity level for the six week period between data collections. If you 
are assigned to the training group, you will be asked not to alter your diet or physical activity 
level and you will attend six weeks of deep slow breathing training at Bellingham Senior 
Activity Center or Blaine Senior Center. 
Testing sessions: Both sessions will involve the same procedures for control and training 
group subjects. You will be asked to complete the Western Ontario and McMaster Universities 
Osteoarthritis (WOMAC) Index, a questionnaire designed to evaluate joint pain and physical 
function. You will be asked to lie on an examination table for five minutes while heart rate 
variability (HRV) measurements are taken. For this measurement, electrodes will be placed on 
the skin of your right arm, right leg, and left leg and you will be required to be completely still 
while data is collected. This is the same procedure as a standard electrocardiogram (EKG), but a 
longer recording of six minutes is taken. You will be asked to complete an expiratory pause, 
performed by breathing in and breathing out then holding your breath until you feel the first urge 
to breathe. The researcher will measure how long you can hold this pause before you feel the 
first urge to breathe. The expiratory pause will be taken three times and the best time will be 
used for data analysis. In addition to these measurements, you will be asked to complete a three 
day diet and exercise log before each data collection. The researcher will provide you with the 
log to fill out and bring with you to each data collection. 
Breathing training sessions: If you are assigned to the training group, you will complete a 
six week deep slow breathing training program. You will attend weekly training sessions with 
the researcher at the Bellingham Senior Activity Center or Blaine Senior Center. You will also 
complete 20-30 minutes of deep slow breathing at home five days a week.  
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As with any breathing exercise, potential risks include feelings of breathlessness, “air 
hunger,” dizziness, light headedness, and/or fainting. If you experience any of these feelings, you 
should alert the researcher immediately. Discomfort during breathing exercises is expected, 
especially during the first training session. Supervision of breathing exercise is done to minimize 
the risk of injury or adverse effects. You may take a break from the exercise if you experience 
discomfort and you may withdraw from participation in this study at any time, without penalty. 
This study is potentially beneficial because it will provide information about the effects 
of deep slow breathing on joint pain. At the conclusion of the study, control subjects will be 
given the opportunity to be trained with the breathing techniques. 
Questions regarding this study and the procedures will be answered by the primary 
researcher, Kalee Larsen, who may be contacted at Kalee.Larsen@wwu.edu or 360-319-4350 or 
Dr. Lorrie Brilla, who may be contacted at Lorrie.Brilla@wwu.edu or 360-650-3056. 
Questions about your rights as a research subject should be directed to Janai Symons, the 
WWU Research Compliance Officer (RCO), at Janai.Symons@wwu.edu or 360-650-3082. If 
you experience injury or any adverse effect from this study, contact Kalee Larsen, Dr. Lorrie 
Brilla, or Janai Symons. 
All data collected will be kept completely confidential. The data will be stored on a 
password protected computer and external hard drive and stored separately from the signed 
consent forms. Data will be analyzed by subject number and only primary researchers will have 
access to the records. 
Your signature indicates that you have read and understand the information provided 
above, that you willingly agree to participate, that you may withdraw your consent at any time 
and discontinue participation without penalty, that you have received a copy of this form, and 
that you are not waiving any legal claims, rights, or remedies. Thank you for your participation 
in this study. 
 
__________________________________________________  _____/_____/_____ 








Physician Clearance Form 
 
Participant’s Name: ____________________________________________________________ 
 Have you read the consent form that describes the procedures for this program? 
  Yes or No 




 _____ Non-participation in the study 
_____ Participation in the study with the following limitations and precautions related to    
_____ the study: 













 _________________________________________   _____/_____/_____  
 Physician’s Full Name (Printed)     Date 
 
 __________________________________________ 
 Physician’s Signature 
99 
 
Health History Form 
 
Name: ____________________________________________________________________ 
Date of Birth: _____________________________ Sex: _____________________________ 
Phone Number: _____________________________________________________________ 
Age: ___________ 
 
Emergency Contact Name: ____________________________________________________ 
Emergency Contact Phone Number: _____________________________________________ 
 
Please check if any of the following has happened to you, indicating the occurrence 
Health Concerns: If so, please date Diseases: If so, please date 
Convulsions  Asthma  
Bowel problems  Bronchitis  
Digestions problems  Chicken pox  
Diabetes  COPD  
Epilepsy  German measles  
Ear infections  Mononucleosis  
Eye trouble  Measles  
Dizziness  Mumps  
Fainting  Pneumonia  
Frequent colds  Poliomyelitis  
Headaches  Rheumatic Fever  
Heart trouble  Scarlet Fever  
Kidney trouble  Tuberculosis  
Neuropathy    
Sleep walking    
Thyroid disorder  Allergies:  
Other (please list)  Hay fever  
  Insect stings  
  Penicillin  
 










Have you or any of your immediate family suffered from: Tuberculosis, Mental Illness, Epilepsy, 
Neuromuscular Disease, Nervous Breakdown, Heart Disease, Asthma, Diabetes, Lung Disease, 

























































































Data Collection Checklist 
Setup 
 Turn computer on 
 Turn on Biopac Systems MP 1500 
 Log into Acknowledge 4.4 
 Prepare electrodes 
 Red wire plugged into VIN+ 
 White wire plugged into VIN- 
 Black wire plugged into GRD 
 Make template using settings on ECG Box 
 Test (if time) to make sure equipment is working properly 
 Items to set out: razor, stop watch, table, WOMAC 
 Set up: Table, space to complete the WOMAC, chair for expiratory pause 
 
WOMAC 
 Give the subject instructions for completing the WOMAC 
 Provide the subject with a #2 pencil 
 Allow subject time to complete the questionnaire 
 Check to make sure all questions have been completed 






Heart Rate Variability 
 Prepare skin by shaving and using an alcohol swab on inside of R wrist and inside of 
L and R ankles about 1 inch above the ankle 
 Remove sticker from electrodes and place at R wrist and R and L ankle sites 
 Instruct subject to lay on table 
 Connect white wire to R wrist 
 Connect red wire to L ankle 
 Connect black wire to R ankle 
 Allow subject to lie on table while instructions are given 
 Inform subject that HRV will be taken for 5 minutes 
 Instruct subject to lie completely still: No moving or talking or they will have to start 
over 
 Select “Start” 
 Record for 5 minutes 
 Select “Stop” 
 Select “Analysis” 
 Select “Heart rate variability” 
 Select output: interpolated tachogram, paste results to journal, and show spectrum 
 Select OK 
 Record variables for HRV on data collection sheet 
 Copy and paste values to excel sheet 
 Save HRV template 




Expiratory Pause  
 Have subject sit in a chair 
 Back straight and feet flat on the floor 
 Instruct subject to breathe normally 
 Instruct subject that they will practice the expiratory pause first 
 Demonstrate the expiratory pause for them 
 Practice the pause with them 
 Breathe in normally 
 Breathe out normally 
 Plug your nose and close your mouth 
 Hold your breath until the very first urge to breathe 
 Then open your mouth and breathe in 
 For measurement: 
 Obtain stopwatch 
 When subject is ready: 
 Breathe in normally 
 Breathe out normally 
 Plug your nose, close your mouth, and hold 
 Record time until subject opens mouth 





Before Subject Leaves 
 WOMAC completed 
 HRV: LF, HF, and LF/HF ratio recorded 



















































_____ WOMAC completed and attached to this sheet 
 
Heart Rate Variability 
Power in VLF band: ____________________________s2 
Power in LF band: _____________________________s2 
Power in HF band: _____________________________s2 






Trial one: _____________________________________ 
Trial two: _____________________________________ 
















_____ WOMAC completed and attached to this sheet 
 
Heart Rate Variability 
Power in VLF band: ____________________________s2 
Power in LF band: _____________________________s2 
Power in HF band: _____________________________s2 






Trial one: _____________________________________ 
Trial two: _____________________________________ 







































Age (years) Height (m) Weight (kg) 
59 1.7 70.8 
67 1.7 68.0 
62 1.6 60.8 
66 1.7 63.5 
70 1.7 64.9 
69 1.7 106.1 
54 1.6 72.6 
58 1.6 72.6 
81 1.6 70.3 
79 1.6 55.8 
 
Control 
Age (years) Height (m) Weight (kg) 
20 1.8 83.9 
79 1.6 59.0 
47 1.7 58.1 
47 1.8 88.5 
27 1.8 83.9 
62 1.6 72.6 
25 1.5 63.5 
57 1.7 61.2 
54 1.7 95.3 
64 1.8 72.6 
 
WOMAC VAS Pain and Physical Function 
Training 
 Pain Physical Function 
ID # Pre Post Change Pre Post Change 
1 113 9 -104 192 28 -164 
2 292 270 -22 285 383 +98 
3 248 136 -112 1042 846 -196 
6 19 57 +38 271 106 -166 
7 112 24 -88 453 123 -330 
9 218 28 -190 363 34 -329 
10 136 27 -109 238 97 -141 
11 230 201 -29 742 692 -50 
12 32 54 +22 272 336 +65 




 Pain Physical Function 
ID # Pre Post Change Pre Post Change 
4 78 53 -25 254 225 -29 
5 129 91 -38 659 368 -292 
8 62 76 +15 175 203 +29 
14 59 73 +14 441 365 -76 
14 260 235 -25 916 830 -86 
15 303 202 -102 1206 804 -403 
16 111 99 -12 240 246 +6 
18 87 57 -30 353 236 -117 
119 80 33 -48 425 55 -370 
20 60 3 -57 153 47 -107 
 
Heart Rate Variability: LF, HF, and LF/HF Ratio 
Training 
 LF Power (ms2) HF Power (ms2) LF/HF Ratio 
ID # Pre Post Change Pre Post Change Pre Post Change 
1 1779.1 0.0260 -1779 127.11 0.0423 -127.1 13.997 0.6140 -13.38 
2 0.0345 0.0241 -0.0104 0.0173 0.0482 +0.0309 1.9978 0.5002 -1.498 
3 2.1444 0.4112 -1.733 1.9859 0.4939 -1.492 1.0797 0.8325 -0.2473 
6 0.1558 0.0666 +0.0892 0.0049 0.0053 +0.0004 31.764 12.555 -19.21 
7 1.2412 0.1853 -1.056 2.9097 0.4254 -2.484 0.4266 0.4356 +0.0090 
9 4.4264 91.818 +87.39 5.2230 61.614 +56.39 0.8474 1.4902 +0.6427 
10 5.6701 0.2654 -5.405 2.9049 0.1054 -2.799 1.9519 2.5174 +0.5654 
11 0.1465 3.8865 +3.740 0.2178 3.9493 +3.731 0.6724 0.9841 +0.3117 
12 0.0108 0.0094 -0.0014 0.0038 0.0100 +0.0062 2.8427 0.9380 -1.905 
17 0.0498 1.4710 +1.421 0.0605 3.4958 +3.435 0.8222 0.4208 -.4014 
 
Control 
 LF Power (ms2) HF Power (ms2) LF/HF Ratio 
ID # Pre Post Change Pre Post Change Pre Post Change 
4 4.9232 0.4258 -4.4973 18.370 1.0183 -17.352 0.2680 0.4182 +0.1502 
5 1.1892 0.3958 -0.7934 0.9354 0.4494 -0.4860 1.2714 0.8807 -0.3906 
8 196.68 0.8059 -195.87 16.030 2.1798 -13.851 12.270 0.3697 -11.900 
13 76.896 1.9612 -74.934 25.814 5.1668 -20.647 2.9789 0.3796 -2.5993 
15 0.0953 0.1105 +0.0152 0.1440 0.1566 +0.0126 0.6619 0.7056 +0.0437 
16 0.2806 0.5358 +0.2552 0.4188 0.4032 -0.0156 0.6700 1.3289 +0.6589 
18 8.5086 0.2983 -8.2103 4.9739 0.1506 -4.8232 1.7107 1.9802 +0.2696 
19 0.0523 1.9893 +1.9370 0.0777 3.9233 +3.8456 0.6730 0.5070 -0.1660 






ID # Pre Post Change 
1 23 17 -6 
2 5 25 +20 
3 28 6 -22 
6 26 32 +6 
7 7 10 +3 
9 36 29 -7 
10 30 32 +2 
11 35 31 -4 
12 11 27 +16 
17 11 23 +12 
 
Control 
ID # Pre Post Change 
4 33 22 -11 
5 25 34 +9 
8 42 36 -6 
13 28 33 +5 
14 18 19 +1 
15 21 21 0 
16 33 32 -1 
18 13 18 +5 
19 34 23 -11 
20 10 13 +3 
 
Training Group Breathing Logs 
At-home breathing (minutes) 
ID # Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 
1 100 100 100 100 100 100 
2 130 130 150 150 150 150 
3 150 150 150 150 150 150 
6 100 110 110 110 82 160 
7 120 135 130 130 130 130 
9 75 142 130 120 123 97 
10 100 100 100 100 100 100 
11 -- 130 -- 100 -- 150 
12 90 106 100 100 100 100 




Diet and Exercise Logs 
Training 
 Diet (kcal in) Exercise (kcal out) 
ID # Pre Post Pre Post 
1 3201.98 2982.56 45.82 50.41 
3 1170.19 936.38 39.08 45.98 
6 1666.97 1409.14 53.22 52.33 
7 1873.92 883.36 49.23 45.81 
9 1241.62 1430.05 45.83 48.79 
10 2931.56 3115.75 53.84 50.82 
11 1172.84 1792.02 40.44 42.46 
19 1097.80 1291.20 57.81 55.81 
 
Control 
 Diet (kcal in) Exercise (kcal out) 
ID # Pre Post Pre Post 
4 2085.84 2100.75 50.51 53.43 
5 1123.36 1396.12 55.64 50.46 
13 2513.25 2615.32 45.95 49.87 
15 1401.73 1605.75 39.68 43.26 
18 1318.84 1265.75 71.84 79.71 













































PainPre Training 148.00 94.062 10 
Control 122.60 87.252 10 
Total 135.30 89.258 20 
PainPost Training 84.10 88.570 10 
Control 91.90 72.543 10 
Total 88.00 78.897 20 
 
 
Mauchly's Test of Sphericitya 














test 1.000 .000 0 . 1.000 1.000 1.000 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed 
dependent variables is proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: test 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected 
















Tests of Within-Subjects Effects 

















































































































     












Tests of Between-Subjects Effects 
Measure:   Pain   




















37.524 .000 .676 37.524 1.000 
Group 774.400 1 774.400 .058 .812 .003 .058 .029 
Error 239190.70
0 
18 13288.372      












Group Mean Std. Deviation N 
FunctionPre Training 433.85 267.529 10 
Control 482.00 346.202 10 
Total 457.93 302.136 20 
FunctionPost Training 275.85 287.362 10 
Control 337.70 273.936 10 
Total 306.77 275.078 20 
 
 
Mauchly's Test of Sphericitya 















test 1.000 .000 0 . 1.000 1.000 1.000 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed 
dependent variables is proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: test 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. 












Tests of Within-Subjects Effects 



























































469.225 1 469.225 .038 .848 .002 .038 .027 
Greenhouse-
Geisser 
469.225 1.000 469.225 .038 .848 .002 .038 .027 
Huynh-Feldt 469.225 1.000 469.225 .038 .848 .002 .038 .027 
Lower-
bound 



































     









Tests of Between-Subjects Effects 
Measure:   Function   































     





WOMAC VAS Pain Change Score 
 
Descriptive Statistics 






-63.90 69.447 10 
Control -30.70 34.045 10 




Tests of Between-Subjects Effects 
Dependent Variable:   PainChange   
Source 
Type III Sum 
of Squares df 
Mean 





5511.200a 1 5511.200 1.843 .191 .093 
Intercept 44745.800 1 44745.800 14.960 .001 .454 
Group 5511.200 1 5511.200 1.843 .191 .093 
Error 53838.000 18 2991.000    
Total 104095.000 20     
Corrected 
Total 
59349.200 19     















-63.900 17.295 -106.185 -21.615 






Dependent Variable:   PainChange   
(I) 






97.5% Confidence Interval 
for Differencea 
Lower Bound Upper Bound 
Training Control -33.200 24.458 .191 -93.000 26.600 
Control Training 33.200 24.458 .191 -26.600 93.000 
Based on estimated marginal means 










Square F Sig. 
Partial Eta 
Squared 
Contrast 5511.200 1 5511.200 1.843 .191 .093 
Error 53838.000 18 2991.000    
The F tests the effect of Group. This test is based on the linearly independent 




WOMAC VAS Physical Function Change Score 
 
Descriptive Statistics 






-158.00 160.235 10 
Control -144.35 154.650 10 









Tests of Between-Subjects Effects 
Dependent Variable:   FuncChange   
Source 
Type III Sum 
of Squares df 
Mean 





931.613a 1 931.613 .038 .848 .002 
Intercept 457077.613 1 457077.613 18.434 .000 .506 
Group 931.613 1 931.613 .038 .848 .002 
Error 446326.525 18 24795.918    
Total 904335.750 20     
Corrected 
Total 
447258.138 19     















-158.000 49.795 -279.750 -36.250 




Dependent Variable:   FuncChange   
(I) 






97.5% Confidence Interval 
for Differencea 
Lower Bound Upper Bound 
Training Control -13.650 70.421 .848 -185.831 158.531 
Control Training 13.650 70.421 .848 -158.531 185.831 
Based on estimated marginal means 














Square F Sig. 
Partial Eta 
Squared 
Contrast 931.613 1 931.613 .038 .848 .002 
Error 446326.525 18 24795.918    
The F tests the effect of Group. This test is based on the linearly independent 










LFPre Training 179.30193 562.129408 10 
Control 32.08216 66.551066 9 
Total 109.56625 407.021860 19 
LFPost Training 9.81471 28.831941 10 
Control .73689 .733494 9 






















Mauchly's Test of Sphericitya 















1.000 .000 0 . 1.000 1.000 1.000 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed 
dependent variables is proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: test 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. 
















Tests of Within-Subjects Effects 









































































































     











Tests of Between-Subjects Effects 
Measure:   LF   




















1.390 .255 .076 1.390 .095 
Group 57858.002 1 57858.002 .690 .418 .039 .690 .052 
Error 1426371.5
55 
17 83904.209      













HFPre Training 14.04388 39.767491 10 
Control 7.43114 9.934835 9 
Total 10.91153 29.087819 19 
HFPost Training 7.01798 19.236342 10 
Control 1.49989 1.872291 9 
Total 4.40415 13.949531 19 
 
 
Mauchly's Test of Sphericitya 














test 1.000 .000 0 . 1.000 1.000 1.000 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed 
dependent variables is proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: test 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected 

















Tests of Within-Subjects Effects 

















397.629 1 397.629 .693 .417 .039 .693 .052 
Greenhouse-
Geisser 
397.629 1.000 397.629 .693 .417 .039 .693 .052 
Huynh-Feldt 397.629 1.000 397.629 .693 .417 .039 .693 .052 
Lower-
bound 





2.838 1 2.838 .005 .945 .000 .005 .017 
Greenhouse-
Geisser 
2.838 1.000 2.838 .005 .945 .000 .005 .017 
Huynh-Feldt 2.838 1.000 2.838 .005 .945 .000 .005 .017 
Lower-
bound 


























573.943      











Tests of Between-Subjects Effects 
Measure:   HF   















2130.568 1 2130.568 4.200 .056 .198 4.200 .303 
Group 348.530 1 348.530 .687 .419 .039 .687 .052 
Error 8624.025 17 507.296      















RatioPre Training 5.64018 10.032318 10 
Control 2.38331 3.793797 9 
Total 4.09745 7.714396 19 
RatioPost Training 2.12875 3.717831 10 
Control .96851 .692760 9 
Total 1.57916 2.734718 19 
 
 
Mauchly's Test of Sphericitya 















test 1.000 .000 0 . 1.000 1.000 1.000 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed 
dependent variables is proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: test 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. 
















Tests of Within-Subjects Effects 



















57.476 1 57.476 3.464 .080 .169 3.464 .246 
Greenhouse-
Geisser 
57.476 1.000 57.476 3.464 .080 .169 3.464 .246 
Huynh-Feldt 57.476 1.000 57.476 3.464 .080 .169 3.464 .246 
Lower-
bound 





10.411 1 10.411 .627 .439 .036 .627 .049 
Greenhouse-
Geisser 
10.411 1.000 10.411 .627 .439 .036 .627 .049 
Huynh-Feldt 10.411 1.000 10.411 .627 .439 .036 .627 .049 
Lower-
bound 






















16.595      













Tests of Between-Subjects Effects 
Measure:   Ratio   















292.905 1 292.905 5.743 .028 .253 5.743 .421 
Group 46.210 1 46.210 .906 .355 .051 .906 .065 
Error 867.102 17 51.006      















PausePre Training 21.20 11.698 10 
Control 25.60 10.211 10 
Total 23.40 10.923 20 
PausePost Training 23.20 9.283 10 
Control 25.10 7.978 10 
Total 24.15 8.481 20 
 
 
Mauchly's Test of Sphericitya 
















1.000 .000 0 . 1.000 1.000 1.000 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed 
dependent variables is proportional to an identity matrix. 
a. Design: Intercept + Group  
 Within Subjects Design: test 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. 





Tests of Within-Subjects Effects 



















5.625 1 5.625 .111 .743 .006 .111 .061 
Greenhouse-
Geisser 
5.625 1.000 5.625 .111 .743 .006 .111 .061 
Huynh-Feldt 5.625 1.000 5.625 .111 .743 .006 .111 .061 
Lower-
bound 





15.625 1 15.625 .307 .586 .017 .307 .082 
Greenhouse-
Geisser 
15.625 1.000 15.625 .307 .586 .017 .307 .082 
Huynh-Feldt 15.625 1.000 15.625 .307 .586 .017 .307 .082 
Lower-
bound 






















50.847      













Tests of Between-Subjects Effects 
Measure:   Pause   















22610.025 1 22610.025 
156.33
6 
.000 .897 156.336 1.000 
Group 99.225 1 99.225 .686 .418 .037 .686 .123 
Error 2603.250 18 144.625      










Expiratory Pause Change Score 
 
 






Group 1 Training 10 








Training 2.0000 12.44544 10 
Control -.6000 6.80196 10 
Total .7000 9.85206 20 
 
 
Levene's Test of Equality of Error 
Variancesa 
Dependent Variable:   PauseChange   
F df1 df2 Sig. 
2.327 1 18 .145 
Tests the null hypothesis that the error 
variance of the dependent variable is equal 
across groups. 










Tests of Between-Subjects Effects 
Dependent Variable:   PauseChange   
Source 
Type III Sum 





33.800a 1 33.800 .336 .569 .018 
Intercept 9.800 1 9.800 .097 .759 .005 
Group 33.800 1 33.800 .336 .569 .018 
Error 1810.400 18 100.578    
Total 1854.000 20     
Corrected Total 1844.200 19     
a. R Squared = .018 (Adjusted R Squared = -.036) 
 
 




Dependent Variable:   PauseChange   
Group Mean Std. Error 





Training 2.000 3.171 -4.663 8.663 
Control -.600 3.171 -7.263 6.063 
 
Pairwise Comparisons 
Dependent Variable:   PauseChange   
(I) 
Group (J) Group 
Mean 
Difference (I-
J) Std. Error Sig.a 
95% Confidence Interval for 
Differencea 
Lower Bound Upper Bound 
Training Control 2.600 4.485 .569 -6.823 12.023 
Control Training -2.600 4.485 .569 -12.023 6.823 
Based on estimated marginal means 







Dependent Variable:   PauseChange   
 
Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Contrast 33.800 1 33.800 .336 .569 .018 
Error 1810.400 18 100.578    
The F tests the effect of Group. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
 
